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Materials and Methods  
Unless otherwise stated, reactions were performed in flame-dried glassware under 
an argon or nitrogen atmosphere using dry, deoxygenated solvents.  Solvents were dried 
by passage through an activated alumina column under argon.1 Reaction progress was 
monitored by thin-layer chromatography (TLC) or Agilent 1290 UHPLC-MS.  TLC was 
performed using E. Merck silica gel 60 F254 precoated glass plates (0.25 mm) and 
visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 staining.  Silicycle 
SiliaFlash® P60 Academic Silica gel (particle size 40–63 nm) was used for flash 
chromatography.  1H NMR spectra were recorded on Varian Inova 500 MHz and Bruker 
400 MHz spectrometers and are reported relative to residual CHCl3 (δ 7.26 ppm).  13C 
NMR spectra were recorded on a Varian Inova 500 MHz spectrometer (125 MHz) and 
Bruker 400 MHz spectrometers (100 MHz) and are reported relative to CHCl3 (δ 77.16 
ppm). Data for 1H NMR are reported as follows: chemical shift (δ ppm) (multiplicity, 
coupling constant (Hz), integration).  Multiplicities are reported as follows: s = singlet, d 
= doublet, t = triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad 
singlet, br d = broad doublet, app = apparent.  Data for 13C NMR are reported in terms of 
chemical shifts (δ ppm).  IR spectra were obtained by use of a Perkin Elmer Spectrum 
BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin films deposited on 
NaCl plates and reported in frequency of absorption (cm–1).  Optical rotations were 
measured with a Jasco P-2000 polarimeter operating on the sodium D-line (589 nm), 
using a 100 mm path-length cell and are reported as: [α]DT (concentration in 10 mg/1 mL, 
solvent).  Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical 
chromatography system utilizing Chiralpak (AD-H, AS-H or IC) or Chiralcel (OD-H, OJ-
H, or OB-H) columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, Ltd.  
High resolution mass spectra (HRMS) were obtained from Agilent 6200 Series TOF with 
an Agilent G1978A Multimode source in electrospray ionization (ESI+), atmospheric 
pressure chemical ionization (APCI+), or mixed ionization mode (MM: ESI-APCI+), or 
obtained from Caltech mass spectrometry laboratory. 
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Reagents were purchased from Sigma-Aldrich, Acros Organics, Strem, or Alfa 
Aesar and used as received unless otherwise stated.  Ligands L1, L4–L6,2 and allyl 
carbonates,3 were prepared by known methods.   
 
List of Abbreviations: 
ee – enantiomeric excess, dr – diastereomeric ratio, SFC – supercritical fluid 
chromatography, TLC – thin-layer chromatography, THF – tetrahydrofuran, IPA – 
isopropanol, TBD – 1,5,7-triazabicyclo[4.4.0]dec-5-ene, cod – cis,cis-1,5-cyclooctadiene. 
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Table S1. Optimization of Reaction Parameters. 
	
a Reactions performed at 0.1 mmol scale in THF (1 mL) at 20 °C for 12–24 h.  b Determined by 1H NMR 
analysis of the crude reaction mixture. c Yield of isolated product 3aa given in parenthesis.  d Determined 
by SFC analysis (Chiralpak AD-H).  e Complex mixture. 			
[Ir(cod)Cl]2 (2 mol %)
ligand (4 mol %)
TBD (10 mol %)
OMe
O
MeO
O
OCO2MePh
MeO2C
1a 2a 3aa
CO2Me
Ph
MeO2C
4aa
CO2Me
Ph
base (x equiv)
solvent, 20 ºC, 12–24 h
entrya base (x equiv) conv (%)b,c 3aa:4aab
1
2
3
4
6
7
8
9
10
LiOt-Bu (1)
NaOt-Bu (2)
KOt-Bu (2)
KOt-Bu (1)
KOt-Bu (0.3)
Cs2CO3 (1)
CsOH•H2O (1)
>95 (28)
>95 (47)
>95 (43)
>95 (57)
32
14
74
1:1
3:1
3:1
3:1
3:1
1:1
3:1
ee of 
3aa (%)d
95
94
97
>99
–
–
–
equiv 
of 1a
2
2
2
2
1.2
1.2
1.2
ligand
L1
L1
L1
L1
L1
L1
L1
solvent
THF
THF
THF
THF
THF
THF
THF
11
12
13
14
KOt-Bu (1)
KOt-Bu (1)
KOt-Bu (1)
2
2
2
L1
L1
L1
dioxane
Et2O
MTBE
CH2Cl2
DCE
toluene
cyclohexane
DMF
MeCN
>95 (54)
90
86
>95
59
94
94
>95
>95
3:1
2:1
2:1
2:1
2:1
2:1
2:1
1:1
1:1
>99
>99
95
97
98
97
97
94
99
5
KOt-Bu (1) 89 3:1 >991.2L1 THF
2
2
2
2
2
2
KOt-Bu (1)
KOt-Bu (1)
KOt-Bu (1)
KOt-Bu (1)
KOt-Bu (1)
KOt-Bu (1)
L1
L1
L1
L1
L1
L1
equiv 
of 2a
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
L2
L3
L6
(±)-L4
L5
L6
L6
LiOt-Bu (1.2) 1THF 1.5
LiOt-Bu (1.2) 1THF 2
KOt-Bu (1) 2THF 1
KOt-Bu (1) 2THF 1
KOt-Bu (1) 2THF 1
KOt-Bu (1) 2THF 1
KOt-Bu (1) 2THF 1
L6 KOt-Bu (1) 1THF 1.5
15
16
17
18
20
21
23
22
24
25
19
N
N
N
HTBD
NaH (2) <5 – –2L1 THF 1
 92 (90)
52
>95
>95 (69)
>95e
<10e
89 (84)
>95 (93)
>20:1 >99
2:1 40
1:1 –
>20:1 >99
>20:1 >99
– –
>20:1 >99
>20:1 >9926
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General Procedure for Optimization Reactions (Table S1):  
All experiments were performed in a nitrogen-filled glove box.  
 To a 2 dram vial (vial A) equipped with a magnetic stirring bar was added 
[Ir(cod)Cl]2 (1.4 mg, 0.002 mmol, 2 mol%), ligand L (0.004 mmol, 4 mol%),  TBD (1.4 
mg, 0.01 mmol, 10 mol%), and 0.5 mL of THF.  Vial A was stirred at 20 °C (~10 min) 
while another 2 dram vial (vial B) was charged with base, 0.5 mL of THF, alkylidene 
malonate 1a, and carbonate 2a.  The pre-formed catalyst solution (vial A) was then 
transferred to vial B.  The vial was sealed, stirred at 20 °C and monitored by TLC or 
UHPLC-MS.  Upon completion of the reaction, the vial was removed from the glovebox 
and the THF removed under reduced pressure.  The resulting residue was dissolved in 
Et2O and filtered through a silica pad, rinsing with Et2O.  The regioselectivity (branched 
to linear) was determined by 1H NMR analysis of this crude mixture.  The residue was 
purified by silica gel flash chromatography (gradient elution, 0→5→10% Et2O in 
hexanes) to afford the desired product. 
 
Dimethyl (R)-2-(cyclohept-1-en-1-yl)-2-(1-phenylallyl)malonate (3aa) 
White solid, >99% ee, [α]D25 –72.1 (c 0.76, CHCl3); Rf = 0.3 (10% Et2O in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.36 – 7.31 (m, 2H), 7.26 – 7.21 (m, 2H), 7.20 – 
7.14 (m, 1H), 6.36 (ddd, J = 17.0, 10.2, 8.9 Hz, 1H), 6.17 (t, J = 6.8 Hz, 1H), 5.06 (ddd, J 
= 10.2, 1.8, 0.8 Hz, 1H), 5.00 (ddd, J = 17.1, 1.8, 1.1 Hz, 1H), 4.29 (d, J = 8.9 Hz, 1H), 
3.68 (s, 3H), 3.61 (s, 3H), 2.18–2.10 (m, 2H), 1.96–1.81 (m, 2H), 1.75–1.66 (m, 1H), 
1.64–1.55 (m, 1H), 1.54–1.31 (m, 3H), 1.31–1.20 (m, 1H); 13C NMR (125 MHz, CDCl3) 
δ 170.7, 170.3, 140.5, 139.2, 138.6, 132.2, 130.2, 127.9, 126.8, 116.9, 70.1, 53.9, 52.3, 
52.2, 32.7, 32.4, 28.7, 26.3, 26.2; IR (Neat Film, NaCl) 2925, 1737, 1728, 1451, 1433, 
1241, 1050 cm-1; HRMS (ESI-APCI+) m/z calc’d for C21H27O4 [M+H]+: 343.1904, found 
343.1905; SFC conditions: 2% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, 
tR (min): minor = 7.34, major = 8.12. 
 
CO2MeMeO2C
Ph
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General Procedure for the Ir-Catalyzed Asymmetric Allylic Alkylation/Cope 
Rearrangement Reactions of Cyclic Alkylidene Malonates. 	
Please note that the absolute configuration was determined only for compound 5a via X-
ray analysis of its derivative (vide infra).  The absolute configuration for all other 
products 5 has been inferred by analogy.  For respective SFC conditions, please refer to 
Table S2.  
 
 
General Procedure A (One-pot): In a nitrogen-filled glove box, [Ir(cod)Cl]2 (2.7 
mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 
0.02 mmol, 10 mol%) were added to a 2 dram vial equipped with a magnetic stirring bar.  
The vial was then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a 
brown solution. To another 2 dram vial was added LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 
equiv), alkylidene malonates 1 (0.2 mmol, 1 equiv), allylic carbonates 2 (0.3–0.4 mmol, 
1.5–2 equiv), and 1 mL of THF.  Then, the above pre-formed catalyst solution was 
transferred to this vial by syringe.  The vial was capped and stirred at 20 °C until the 
alkylidene malonate was fully consumed, as indicated by TLC or UHPLC-MS analysis.  
Upon completion of the reaction, the vial was removed from the glovebox and the THF 
removed under reduced pressure.  The regioselectivity (branched to linear, b:l >20:1 for 
all cases) was determined by 1H NMR of the crude reaction mixture.  The crude sample 
was recovered from the NMR tube and concentrated.  The resulting residue was dissolved 
in 2 mL of toluene, placed in a sealed vial, and stirred at 100 °C for 5 h.  After removal of 
the solvent, the residue was purified by silica gel flash chromatography to afford the 
desired product. 
General Procedure B (Column Separation): In a nitrogen-filled glove box, 
[Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 0.008 mmol, 4 mol%), 
and TBD (2.8 mg, 0.02 mmol, 10 mol%) were added to a 2 dram vial equipped with a 
1) [Ir(cod)Cl]2 (2 mol %)
L5 (4 mol %)
TBD (10 mol %)
LiOt-Bu (1.2 equiv)
THF, 20 °C, 12–16 h
Ar OCO2Me
1 2
+
2) filtration (General Procedure A)
 or 
column separation (General Procedure B)
    toluene, 100 °C, 5 h
X
CO2MeMeO2C
n
5
X
CO2MeMeO2C
n
Ar
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magnetic stirring bar.  The vial was then charged with THF (1 mL) and stirred at 20 °C 
for 10 min, generating a brown solution. To another 2 dram vial was added LiOt-Bu (19.2 
mg, 0.24 mmol, 1.2 equiv), alkylidene malonates 1 (0.2 mmol, 1 equiv), allylic 
carbonates 2 (0.3–0.4 mmol, 1.5–2 equiv), and 1 mL of THF.  Then the above pre-formed 
catalyst solution was transferred to this vial by syringe.  The vial was capped and stirred 
at 20 °C until the alkylidene malonate was fully consumed, as indicated by TLC or 
UHPLC-MS analysis.  Upon completion of the reaction, the vial was removed from the 
glovebox and the THF removed under reduced pressure.  The regioselectivity (branched 
to linear: b:l >20:1 for all cases) was determined by 1H NMR of the crude reaction 
mixture. The residue was then purified by silica gel flash chromatography to afford the 
desired allylation product, which was then dissolved in 2 mL of toluene, sealed and 
stirred for 5 h at 100 °C.  After removal of the solvent, the residue was purified by silica 
gel flash chromatography to afford the desired product. 
 
 
Dimethyl (S)-2-(2-cinnamylcyclohexylidene)malonate 5aa: The General Procedure A 
was followed.  To a 2 dram scintillation vial equipped with a magnetic stirring bar was 
added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 0.008 mmol, 4 
mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was then charged with THF 
(1 mL) and stirred at 20 °C for 10 min, generating a light brown solution.  To another 2 
dram scintillation vial equipped with a magnetic stirring bar was charged with LiOt-Bu 
(19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-cyclohexylidenemalonate 1a (45.2 mg, 0.2 
mmol, 1 equiv),  and cinnamyl carbonate 2a (76.8 mg, 0.4 mmol, 2.0 equiv), and 1 mL of 
THF.  After the transformation of above prepared catalyst solution by syringe, the vial 
was sealed and stirred at 20 °C for 12 h, until 2-cyclohexylidenemalonate 1a was fully 
consumed, as indicated by TLC or UHPLC-MS analysis.  Upon completion of the 
reaction the vial was removed from the glovebox, uncapped, and THF was evaporated 
under reduced pressure.  Et2O was added to the crude mixture and the resulting 
precipitate was filtered through a silica pad, rinsed with Et2O and the filtrate was 
CO2MeMeO2C
Ph
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concentrated under reduced pressure. The regioselectivity (branched product to linear 
product: b:l) was determined by 1H NMR of this crude mixture as >20:1. This crude oil 
was then dissolved in 2 mL of toluene and stirred at 100 ºC for 5 h.  After the evaporation 
of toluene under reduced pressure, the desired product 5aa (62.4 mg, 91% yield) was 
obtained as a colorless oil after purification by silica gel flash chromatography (gradient 
elution, 10→20% Et2O in hexanes). 96% ee; [α]D25 –111.1 (c 0.72, CHCl3); Rf = 0.2 
(10% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.31 – 7.27 
(m, 2H), 7.22 – 7.16 (m, 1H), 6.37 (d, J = 15.7 Hz, 1H), 6.17 (ddd, J = 15.5, 8.1, 6.8 Hz, 
1H), 3.77 (s, 3H), 3.74 (s, 3H), 3.13 (ddt, J = 11.0, 8.4, 5.7 Hz, 1H), 2.99 – 2.90 (m, 1H), 
2.45 – 2.40 (m, 1H), 2.28 – 2.22 (m, 1H), 2.11 – 1.96 (m, 3H), 1.87 – 1.69 (m, 2H), 1.51 
– 1.39 (m, 1H), 1.36 – 1.24 (m, 2H), 1.17 – 1.04 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 
168.3, 166.5, 165.8, 137.7, 131.8, 128.6, 127.9, 127.1, 126.2, 124.6, 52.2, 52.1, 44.4, 
39.9, 31.7, 30.9, 29.8, 29.6, 25.9; IR (Neat Film, NaCl) 2924, 1723, 1618, 1433, 1231, 
1192, 1068 cm-1; HRMS (FAB+) m/z calc’d for C21H27O4 [M+H]+: 343.1909, found 
343.1919; SFC conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, 
tR (min): major = 4.55, minor = 4.88. 
 
  
Dimethyl (S,E)-2-(2-(3-(p-tolyl)allyl)cycloheptylidene)malonate 5ab: The General 
Procedure B was followed.  To a 2 dram scintillation vial equipped with a magnetic 
stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 
0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was then 
charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-
cycloheptylidenemalonate 1a (45.2 mg, 0.2 mmol, 1 equiv), and p-methylcinnamyl 
carbonate 2b (82.4 mg, 0.4 mmol, 2.0 equiv), and 1 mL of THF.  After the transformation 
of above prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 
12 h, the vial was removed from the glovebox, uncapped, and THF was evaporated under 
MeO2C CO2Me
Me
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reduced pressure.  Et2O was added to the crude mixture and the resulting precipitate was 
filtered through a silica pad, rinsed with Et2O and the filtrate was concentrated under 
reduced pressure. The regioselectivity (branched product to linear product: b:l) was 
determined by 1H NMR of this crude mixture as >20:1. The residue was purified by silica 
gel flash chromatography (gradient elution, 10→20% Et2O in hexanes) to afford a 
colorless oil.   This oil was then dissolved in 2 mL of toluene and stirred at 100 ºC for 5 h.  
After the evaporation of toluene under reduced pressure, the desired product 5ab (56.5 
mg, 79% yield) was obtained as a colorless oil after purification by silica gel flash 
chromatography (10% Et2O in hexanes).  96% ee, [α]D25 –107.2 (c 1.67, CHCl3); Rf = 0.2 
(10% Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.26 – 7.21 (m, 2H), 7.14 – 7.06 
(m, 2H), 6.34 (d, J = 15.7 Hz, 1H), 6.11 (ddd, J = 15.4, 8.1, 6.8 Hz, 1H), 3.76 (s, 3H), 
3.74 (s, 3H), 3.14 – 3.08 (m, 1H), 3.01 – 2.89 (m, 1H), 2.44 – 2.38 (m, 1H), 2.32 (s, 3H), 
2.28 – 2.17 (m, 1H), 2.11 – 1.94 (m, 3H), 1.87 – 1.70 (m, 2H), 1.50 – 1.39 (m, 1H), 1.36 
– 1.23 (m, 2H), 1.15 – 1.03 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 168.3, 166.5, 165.7, 
136.8, 134.9, 131.6, 129.3, 126.7, 126.0, 124.5, 52.1, 52.0, 44.5, 39.9, 31.6, 30.8, 29.7, 
29.6, 25.9, 21.3.  IR (Neat Film, NaCl) 3022, 2924, 2855, 1727, 1615, 1513, 1434, 1294, 
1276, 1231, 1192, 1070, 1045, 1028, 967, 790 cm–1; HRMS (MM: ESI-APCI+) calc’d 
for C22H29O4 [M+H]+: 357.2060, found 357.2059.  SFC conditions: 5% IPA, 2.5 mL/min, 
Chiralpak IC column, λ = 254 nm, tR (min): major = 7.54, minor = 10.52. 
 
 
Dimethyl (S)-2-(2-(3-(4-methoxyphenyl)allyl)cycloheptylidene)malonate 5ac: The 
General Procedure B was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-
cycloheptylidenemalonate 1a (45.2 mg, 0.2 mmol, 1 equiv),  and p-methoxylcinnamyl 
MeO2C CO2Me
OMe
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carbonate 2c (88.8 mg, 0.4 mmol, 2.0 equiv), and 1 mL of THF.  After the transformation 
of above prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 
12 h.  Then the vial was removed from the glovebox, uncapped, and THF was evaporated 
under reduced pressure.  Et2O was added to the crude mixture and the resulting 
precipitate was filtered through a silica pad, rinsed with Et2O and the filtrate was 
concentrated under reduced pressure.  The regioselectivity (branched product to linear 
product: b:l) was determined by 1H NMR of this crude mixture as >20:1. The residue was 
purified by silica gel flash chromatography (gradient elution, 10→20% Et2O in hexanes) 
to afford a colorless oil.   This oil was then dissolved in 2 mL of toluene and stirred at 
100 ºC for 5 h.  After the evaporation of toluene under reduced pressure, the desired 
product 5ac (53.6 mg, 72% yield) was obtained as a colorless oil after purification by 
silica gel flash chromatography (gradient elution, 10→20% Et2O in hexanes). 96% ee, 
[α]D25 –72.7 (c 1.42, CHCl3);  Rf = 0.4 (25% Et2O in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 7.23 – 7.17 (m, 2H), 6.79 – 6.73 (m, 2H), 6.24 (dt, J = 15.7, 1.3 Hz, 1H), 5.94 
(ddd, J = 15.6, 8.1, 6.8 Hz, 1H), 3.72 (s, 3H), 3.69 (s, 3H), 3.66 (s, 3H), 3.06 – 3.00 (m, 
1H), 2.91 – 2.83 (m, 1H), 2.35 – 2.30 (dddd, J = 13.5, 6.8, 5.3, 1.5 Hz, 1H), 2.15 (dtd, J = 
13.5, 8.3, 1.2 Hz, 1H), 2.02 – 1.88 (m, 3H), 1.77 – 1.62 (m, 2H), 1.43 – 1.30 (m, 1H), 
1.29 – 1.15 (m, 2H), 1.05 – 0.98 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 168.4, 166.5, 
165.7, 158.9, 131.1, 130.5, 127.3, 125.6, 124.5, 114.0, 55.4, 52.2, 52.1, 44.5, 39.9, 31.6, 
30.8, 29.7, 29.6, 25.9.  IR (Neat Film, NaCl) 2928, 2854, 1725, 1608, 1577, 1511, 1434, 
1292, 1276, 1233, 1192, 1174, 1139, 1070, 1034, 967 cm–1; HRMS (MM: ESI-APCI+) 
calc’d for C22H29O5 [M+H]+: 373.2010, found 373.2016.  SFC conditions: 10% IPA, 2.5 
mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 7.39, minor = 9.02. 
 
 
Dimethyl (S,E)-2-(2-(3-(3-methoxyphenyl)allyl)cycloheptylidene)malonate 5ad: The 
General Procedure A was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
MeO2C CO2Me OMe
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then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-
cycloheptylidenemalonate 1a (45.2 mg, 0.2 mmol, 1 equiv),  and m-methoxycinnamyl 
carbonate 2d (88.8 mg, 0.4 mmol, 2 equiv), and 1 mL of THF.  After the transformation 
of above prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 
16 h, the vial was removed from the glovebox, uncapped, and THF was evaporated under 
reduced pressure.  Et2O was added to the crude mixture and the resulting precipitate was 
filtered through a silica pad, rinsed with Et2O and the filtrate was concentrated under 
reduced pressure. The regioselectivity (branched product to linear product: b:l) was 
determined by 1H NMR of this crude mixture as >20:1.  The mixture was recovered from 
NMR tube, concentrated, and dried under vacuum.  Then this crude mixture was 
dissolved in 2 mL of toluene and stirred at 100 ºC for 5 h.  After the evaporation of 
toluene under reduced pressure, the desired product 5ad (67.3 mg, 90% yield) was 
obtained as a colorless oil after purification by silica gel flash chromatography (gradient 
elution, 10→20% Et2O in hexanes). 97% ee, [α]D25 –98.0 (c 1.35, CHCl3);  Rf = 0.1 (10% 
Et2O in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.20 (t, J = 7.9 Hz, 1H), 6.94 (dt, J = 
7.5, 1.3 Hz, 1H), 6.88 (dd, J = 2.6, 1.6 Hz, 1H), 6.76 (ddd, J = 8.2, 2.6, 0.9 Hz, 1H), 6.35 
(dt, J = 15.9, 1.3 Hz, 1H), 6.16 (ddd, J = 15.7, 8.1, 6.7 Hz, 1H), 3.81 (s, 3H), 3.76 (s, 3H), 
3.74 (s, 3H), 3.19 – 3.08 (m, 1H), 3.00 – 2.86 (m, 1H), 2.45 – 2.39 (m, 1H), 2.29 – 2.18 
(m, 1H), 2.12 – 1.92 (m, 3H), 1.86 – 1.68 (m, 2H), 1.51 – 1.37 (m, 1H), 1.37 – 1.19 (m, 
2H), 1.16 – 1.03 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 168.2, 166.4, 165.7, 159.9, 
139.1, 131.7, 129.5, 128.2, 124.5, 118.9, 112.8, 111.5, 55.3, 52.2, 52.1, 44.3, 39.8, 31.6, 
30.8, 29.8, 29.6, 25.9.  IR (Neat Film, NaCl) 2997, 2945, 2927, 2854, 1725, 1598, 1579, 
1488, 1434, 1289, 1231, 1192, 1165, 1155, 1070, 1044, 968, 940, 775 cm–1; HRMS 
(MM: ESI-APCI+) calc’d for C22H29O5 [M+H]+: 373.2010, found 373.2001.  SFC 
conditions: 5% MeOH, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 
9.50, minor = 10.16. 
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Dimethyl (S,E)-2-(2-(3-(3-chlorophenyl)allyl)cycloheptylidene)malonate 5ae: The 
General Procedure A was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-
cycloheptylidenemalonate 1a (45.2 mg, 0.2 mmol, 1 equiv),  and m-chlorocinnamyl 
carbonate 2e (90.4 mg, 0.4 mmol, 2.0 equiv), and 1 mL of THF.  After the transformation 
of above prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 
12 h, the vial was removed from the glovebox, uncapped, and THF evaporated under 
reduced pressure.  Et2O was added to the crude mixture and the resulting precipitate was 
filtered through a silica pad, rinsed with Et2O and the filtrate was concentrated under 
reduced pressure.  The regioselectivity (branched product to linear product: b:l) was 
determined by 1H NMR of this crude mixture as >20:1.  The mixture was recovered from 
NMR tube, concentrated, and dried under vacuum.  Then this crude mixture was 
dissolved in 2 mL of toluene and stirred at 100 ºC for 5 h.  After the evaporation of 
toluene under reduced pressure, the desired product 5ae (73.3 mg, 97% yield) was 
obtained as a colorless oil after purification by silica gel flash chromatography (10% 
Et2O in hexanes). 96% ee, [α]D25 –88.1 (c 1.27, CHCl3);  Rf = 0.3 (10% Et2O in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.34 – 7.30 (m, 1H), 7.24 – 7.18 (m, 2H), 7.18 – 7.11 (m, 
1H), 6.31 (dt, J = 15.6, 1.2 Hz, 1H), 6.18 (ddd, J = 15.7, 8.0, 6.8 Hz, 1H), 3.76 (s, 3H), 
3.73 (s, 3H), 3.15 (ddt, J = 11.3, 8.4, 5.8 Hz, 1H), 2.95 – 2.87 (m, 1H), 2.41 (dddd, J = 
13.5, 6.8, 5.5, 1.4 Hz, 1H), 2.24 (dtd, J = 13.5, 8.1, 1.0 Hz, 1H), 2.09 – 1.94 (m, 3H), 1.85 
– 1.72 (m, 2H), 1.50 – 1.37 (m, 1H), 1.36 – 1.20 (m, 2H), 1.15 – 1.03 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 167.9, 166.4, 165.8, 139.6, 134.5, 130.5, 129.8, 129.6, 127.1, 126.1, 
124.7, 124.4, 52.2, 52.1, 44.1, 39.8, 31.7, 30.8, 29.8, 29.6, 25.9.  IR (Neat Film, NaCl) 
2927, 2854, 1726, 1619, 1615, 1593, 1434, 1294, 1276, 1231, 1192, 1140, 1070, 1045, 
MeO2C CO2Me Cl
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1028, 964, 776 cm–1; HRMS (FAB+) m/z calc’d for C21H26ClO4 [M+H]+: 377.1520, 
found 377.1503. SFC conditions: 3% IPA, 4 mL/min, Chiralpak IC column, λ = 254 nm, 
tR (min): major = 12.00, minor = 17.72. 
 
 
Dimethyl (S,E)-2-(2-(3-(4-bromophenyl)allyl)cycloheptylidene)malonate 5af: The 
General Procedure A was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-
cycloheptylidenemalonate 1a (45.2 mg, 0.2 mmol, 1 equiv),  and p-bromocinnamyl 
carbonate 2f (81.0 mg, 0.3 mmol, 1.5 equiv), and 1 mL of THF.  After the transformation 
of above prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 
12 h, the vial was removed from the glovebox, uncapped, and THF evaporated under 
reduced pressure.  Et2O was added to the crude mixture and the resulting precipitate was 
filtered through a silica pad, rinsed with Et2O and the filtrate was concentrated under 
reduced pressure. The regioselectivity (branched product to linear product: b:l) was 
determined by 1H NMR of this crude mixture as >20:1. The residue was purified by silica 
gel flash chromatography (10% Et2O in hexanes) to afford a colorless oil.   This oil was 
then dissolved in 2 mL of toluene and stirred at 100 ºC for 5 h.  After the evaporation of 
toluene under reduced pressure, the desired product 5af (80.2 mg, 95% yield) was 
obtained as a colorless oil after purification by silica gel flash chromatography (10% 
Et2O in hexanes). 97% ee, [α]D25 –69.9 (c 1.66, CHCl3);  Rf = 0.3 (10% Et2O in hexanes); 
1H NMR (500 MHz, CDCl3) δ 7.45 – 7.35 (m, 2H), 7.25 – 7.16 (m, 2H), 6.30 (d, J = 15.6 
Hz,  1H), 6.15 (ddd, J = 15.6, 8.0, 6.8 Hz, 1H), 3.76 (s, 3H), 3.72 (s, 3H), 3.17 – 3.11 (m, 
1H), 2.96 – 2.87 (m, 1H), 2.42 – 2.36 (m, 1H), 2.27 – 2.20 (m, 1H), 2.08 – 1.94 (m, 3H), 
1.85 – 1.71 (m, 2H), 1.50 – 1.37 (m, 1H), 1.35 – 1.22 (m, 2H), 1.13 – 1.05 (m, 1H); 13C 
MeO2C CO2Me
Br
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NMR (125 MHz, CDCl3) δ 167.9, 166.4, 165.8, 136.6, 131.7, 130.6, 128.8, 127.7, 124.7, 
120.8, 52.2, 52.1, 44.2, 39.8, 31.8, 30.8, 29.7, 29.6, 25.9.  IR (Neat Film, NaCl) 2927, 
2855, 1726, 1619, 1615, 1593, 1567, 1434, 1294, 1276, 1231, 1193, 1140, 1070, 1028, 
964, 777 cm–1; HRMS (MM: ESI-APCI+) calc’d for C21H24O4Br [M–H2+H]+: 419.0852, 
found 419.0847.  SFC conditions: 9% MeOH, 2.5 mL/min, Chiralpak IC column, λ = 254 
nm, tR (min): major = 5.33, minor = 5.85. 
 
  
Dimethyl (S,E)-2-(2-(3-(thiophen-2-yl)allyl)cycloheptylidene)malonate 5ag: The 
General Procedure A was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-
cycloheptylidenemalonate 1a (45.2 mg, 0.2 mmol, 1 equiv),  and (E)-methyl (3-
(thiophen-2-yl)allyl) carbonate 2g (79.2 mg, 0.4 mmol, 2 equiv), and 1 mL of THF.  
After the transformation of above prepared catalyst solution by syringe, the vial was 
sealed and stirred at 20 °C for 16 h. then the vial was removed from the glovebox, 
uncapped, and THF was evaporated under reduced pressure.  Et2O was added to the crude 
mixture and the resulting precipitate was filtered through a silica pad, rinsed with Et2O 
and the filtrate was concentrated under reduced pressure.  The regioselectivity (branched 
product to linear product: b:l) was determined by 1H NMR of this crude mixture as 
>20:1.  The residue was recovered from the NMR tube, solvents were removed, and dried 
under high vacuum to form a yellow oil.   This oil was then dissolved in 2 mL of toluene 
and stirred at 100 ºC for 5 h.  After the evaporation of toluene under reduced pressure, the 
desired product 5ag was obtained after purification by silica gel flash chromatography 
(10% Et2O in hexanes) as a inseparable mixture with 1a (65.7 mg of mixture, contains 
64.0 mg of 5ag based on 1H NMR, 92% yield). The analytic pure product was obtained 
MeO2C CO2Me
S
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by preparative HPLC (ACE 5 C18, 250 x 21 2mm id column; gradient, 15–100% MeCN 
in H2O in 2 min, then 100% MeCN; flow rate = 10 mL/min; λ = 254 nm) as a colorless 
oil.  96% ee, [α]D25 –97.3 (c 1.82, CHCl3);  Rf = 0.2 (10% Et2O in hexanes); 1H NMR 
(400 MHz, CDCl3) δ 7.09 (dt, J = 5.1, 0.9 Hz, 1H), 6.92 (dd, J = 5.1, 3.5 Hz, 1H), 6.87 
(d, J = 3.3 Hz, 1H), 6.50 (d, J = 15.5 Hz, 1H), 5.99 (ddd, J = 15.3, 8.1, 6.9 Hz, 1H), 3.75 
(s, 3H), 3.75 (s, 3H), 3.15 – 3.08 (m, 1H), 3.00 – 2.84 (m, 1H), 2.42 – 2.36 (m, 1H), 2.28 
– 2.10 (m, 1H), 2.10 – 1.90 (m, 3H), 1.90 – 1.65 (m, 2H), 1.54 – 1.37 (m, 1H), 1.34 – 
1.23 (m, 2H), 1.17 – 0.94 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 168.1, 166.4, 165.7, 
142.8, 127.7, 127.3, 125.0, 124.7, 124.6, 123.5, 52.2, 52.1, 44.3, 39.7, 31.6, 30.8, 29.8, 
29.6, 25.9.  IR (Neat Film, NaCl) 2927, 2855, 1726, 1619, 1615, 1593, 1567, 1434, 1294, 
1276, 1231, 1193, 1140, 1070, 1028, 964, 777 cm–1; HRMS (MM: ESI-APCI+) calc’d 
for C19H25O4S [M+H]+: 349.1468, found 349.1469.  SFC conditions: 3% MeOH, 2.5 
mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 11.55, minor = 12.69. 
 
 
Dimethyl (S)-2-(2-cinnamylcyclohexylidene)malonate 5ba: The General Procedure B 
was followed.  To a 2 dram scintillation vial equipped with a magnetic stirring bar was 
added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 0.008 mmol, 4 
mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was then charged with THF 
(1 mL) and stirred at 20 °C for 10 min, generating a light brown solution.  To another 2 
dram scintillation vial equipped with a magnetic stirring bar was charged with LiOt-Bu 
(19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-cyclohexylidenemalonate 1b (42.4 mg, 0.2 
mmol, 1 equiv),  and cinnamyl carbonate 2a (76.8 mg, 0.4 mmol, 2.0 equiv), and 1 mL of 
THF.  After the transformation of above prepared catalyst solution by syringe, the vial 
was sealed and stirred at 20 °C for 12 h, the vial was removed from the glovebox, 
uncapped, and THF was evaporated under reduced pressure.  Et2O was added to the crude 
mixture and the resulting precipitate was filtered through a silica pad, rinsed with Et2O 
and the filtrate was concentrated under reduced pressure. The regioselectivity (branched 
product to linear product: b:l) was determined by 1H NMR of this crude mixture as 
CO2MeMeO2C
Ph
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>20:1. The residue was purified by silica gel flash chromatography (10% Et2O in 
hexanes) to afford a colorless oil.   This oil was then dissolved in 2 mL of toluene and 
stirred at 100 ºC for 5 h.  After the evaporation of toluene under reduced pressure, the 
desired product 5ba (54.3 mg, 83% yield) was obtained as a colorless oil after 
purification by silica gel flash chromatography (gradient elution, 10→20% Et2O in 
hexanes). 91% ee, [α]D25 –36.3 (c 0.73, CHCl3); Rf = 0.2 (10% Et2O in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.39 – 7.32 (m, 2H), 7.32 – 7.27 (m, 2H), 7.23 – 7.16 (m, 
1H), 6.40 (d, J = 15.7 Hz, 1H), 6.14 (ddd, J = 15.6, 7.8, 6.8 Hz, 1H), 3.76 (s, 3H), 3.72 (s, 
3H), 3.29 – 3.21 (m, 1H), 3.05 – 2.96 (m, 1H), 2.55 – 2.42 (m, 2H), 2.17 (td, J = 13.9, 4.9 
Hz, 1H), 1.98 – 1.91 (m, 1H), 1.91 – 1.84 (m, 1H), 1.74 – 1.56 (m, 3H), 1.53 – 1.39 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 166.3, 166.2, 164.4, 137.7, 131.7, 128.6, 128.2, 
127.2, 126.2, 122.2, 52.24, 52.18, 39.7, 35.6, 30.5, 27.9, 27.8, 20.3.  IR (Neat Film, 
NaCl) 2933, 2858, 1727, 1626, 1599, 1495, 1449, 1434, 1365, 1336, 1296, 1271, 1251, 
1216, 1143, 1103, 1085, 1058, 1016, 966, 743 cm–1; HRMS (FAB+) m/z calc’d for 
C20H25O4 [M+H]+: 329.1753, found 329.1750; SFC conditions: 15% IPA, 2.5 mL/min, 
Chiralcel OJ-H column, λ = 254 nm, tR (min): minor = 2.87, major = 4.16. 
 
  
Dimethyl (S)-2-(2-cinnamylcyclopentylidene)malonate 5ca: The General Procedure B 
was followed.  To a 2 dram scintillation vial equipped with a magnetic stirring bar was 
added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 0.008 mmol, 4 
mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was then charged with THF 
(1 mL) and stirred at 20 °C for 10 min, generating a light brown solution.  To another 2 
dram scintillation vial equipped with a magnetic stirring bar was charged with LiOt-Bu 
(19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-cyclopentylidenemalonate 1c (40.1 mg, 0.2 
mmol, 1 equiv),  and cinnamyl carbonate 2a (76.8 mg, 0.4 mmol, 2.0 equiv), and 1 mL of 
THF.  After the transformation of above prepared catalyst solution by syringe, the vial 
was sealed and stirred at 20 °C for 12 h.  Then the vial was removed from the glovebox, 
uncapped, and THF was evaporated under reduced pressure.  Et2O was added to the crude 
mixture and the resulting precipitate was filtered through a silica pad, rinsed with Et2O 
CO2MeMeO2C
Ph
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and the filtrate was concentrated under reduced pressure. The regioselectivity (branched 
product to linear product: b:l) was determined by 1H NMR of this crude mixture as 
>20:1. The residue was purified by silica gel flash chromatography (10% Et2O in 
hexanes) to afford a colorless oil.   This oil was then dissolved in 2 mL of toluene and 
stirred at 100 ºC for 5 h.  After the evaporation of toluene under reduced pressure, the 
desired product 5ca (47.2 mg, 75% yield) was obtained as a colorless oil after 
purification by silica gel flash chromatography (gradient elution, 10→20% Et2O in 
hexanes). 90% ee, [α]D25 –49.9 (c 1.13, CHCl3); Rf = 0.2 (10% Et2O in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.37 – 7.33 (m, 2H), 7.31 – 7.28 (m, 2H), 7.23 – 7.18 (m, 1H), 
6.38 (dt, J = 15.8, 1.3 Hz, 1H), 6.16 (ddd, J = 15.7, 8.2, 6.3 Hz, 1H), 3.78 (s, 3H), 3.75 (s, 
3H), 3.36 – 3.32 (m, 1H), 2.82 – 2.74 (m, 1H), 2.74 – 2.60 (m, 1H), 2.46 – 2.40 (m, 1H), 
2.18 – 2.11 (m, 1H), 1.87 – 1.68 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 172.3, 165.9, 
137.5, 131.9, 131.9, 128.6, 128.2, 127.2, 126.2, 120.6, 52.2, 52.1, 44.6, 36.9, 33.5, 30.3, 
22.8.  IR (Neat Film, NaCl) 2951, 2877, 1725, 1634, 1598, 1494, 1435, 1317, 1274, 
1232, 1194, 1173, 1061, 1013, 968, 743 cm–1; HRMS (MM: ESI-APCI+) calc’d for 
C19H23O4 [M+H]+: 315.1591, found 315.1600.  SFC conditions: 10% IPA, 2.5 mL/min, 
Chiralpak AD-H column, λ = 254 nm, tR (min): minor = 4.41, major = 4.79. 
 
   
Dimethyl (S)-2-(3-cinnamyltetrahydro-4H-pyran-4-ylidene)malonate 5da: The 
General Procedure B was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-(tetrahydro-4H-
pyran-4-ylidene)malonate 1d (42.8 mg, 0.2 mmol, 1 equiv),  and cinnamyl carbonate 2a 
(76.8 mg, 0.4 mmol, 2.0 equiv), and 1 mL of THF.  After the transformation of above 
prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 12 h, 
O
CO2MeMeO2C
Ph
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until 2-cyclopentylidenemalonate 1d was fully consumed, as indicated by TLC or 
UHPLC-MS analysis.  Upon completion of the reaction the vial was removed from the 
glovebox, uncapped, and THF was evaporated under reduced pressure.  Et2O was added 
to the crude mixture and the resulting precipitate was filtered through a silica pad, rinsed 
with Et2O and the filtrate was concentrated under reduced pressure. The regioselectivity 
(branched product to linear product: b:l) was determined by 1H NMR of this crude 
mixture as >20:1. The residue was purified by silica gel flash chromatography (10% Et2O 
in hexanes) to afford a colorless oil.   This oil was then dissolved in 2 mL of toluene and 
stirred at 100 ºC for 5 h.  After the evaporation of toluene under reduced pressure, the 
desired product 5da (60.3 mg, 91% yield) was obtained as a colorless oil after 
purification by silica gel flash chromatography (gradient elution, 10→20% Et2O in 
hexanes). 94% ee, [α]D25 –52.9 (c 1.26, CHCl3); Rf = 0.2 (10% Et2O in hexanes); 1H 
NMR (500 MHz, CDCl3) δ 7.37 – 7.32 (m, 2H), 7.30 – 7.27 (m, 2H), 7.24 – 7.14 (m, 1H), 
6.46 (dt, J = 15.7, 1.3 Hz, 1H), 6.16 (ddd, J = 15.7, 8.2, 6.6 Hz, 1H), 4.11 (dd, J = 11.1, 
6.1 Hz, 1H), 3.99 (dt, J = 11.6, 1.3 Hz, 1H), 3.77 (s, 3H), 3.72 (s, 3H), 3.53 (dd, J = 11.6, 
2.8 Hz, 1H), 3.47 (ddd, J = 12.5, 11.1, 2.5 Hz, 1H), 3.09 (t, J = 7.3 Hz, 1H), 2.94 (d, J = 
14.8 Hz, 1H), 2.68 (dtd, J = 13.7, 8.4, 1.2 Hz, 1H), 2.61 – 2.52 (m, 2H); 13C NMR (125 
MHz, CDCl3) δ 165.7, 158.8, 137.4, 132.6, 128.6, 127.3, 127.2, 126.2, 123.3, 70.2, 68.4, 
52.4, 52.3, 41.1, 35.0, 29.0.  IR (Neat Film, NaCl) 2952, 2847, 1725, 1633, 1495, 1434, 
1384, 1299, 1245, 1228, 1102, 1067, 1047, 1031, 967 cm–1; HRMS (MM: ESI-APCI+) 
calc’d for C19H23O5 [M+H]+: 331.1540, found 331.1544.  SFC conditions: 15% IPA, 2.5 
mL/min, Chiralcel OJ-H column, λ = 254 nm, tR (min): minor = 2.79, major = 4.44. 
 
  
Dimethyl (S)-2-(3-cinnamyltetrahydro-4H-thiopyran-4-ylidene)malonate 5ea: The 
General Procedure A was followed.  To a 2 dram scintillation vial equipped with a 
magnetic stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 
(4.9 mg, 0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was 
then charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
S
CO2MeMeO2C
Ph
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solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-(tetrahydro-4H-
thiopyran-4-ylidene)malonate 1e (46.0 mg, 0.20 mmol, 1.0 equiv), cinnamyl carbonate 2a 
(76.8 mg, 0.4 mmol, 2.0 equiv), and 1 mL of THF.  After the transformation of above 
prepared catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 12 h, the 
vial was removed from the glovebox, uncapped, and THF was evaporated under reduced 
pressure.  Et2O was added to the crude mixture and the resulting precipitate was filtered 
through a silica pad, rinsed with Et2O and the filtrate was concentrated under reduced 
pressure.  The regioselectivity (branched product to linear product: b:l) was determined 
by 1H NMR of this crude mixture as >20:1. The mixture was recovered from NMR tube, 
concentrated, and dried under vacuum.  Then this crude mixture was dissolved in 2 mL of 
toluene and stirred at 100 ºC for 5 h.  After the evaporation of toluene under reduced 
pressure, the desired product 5ae (38.7 mg, 56% yield) was obtained as a colorless oil 
after purification by silica gel flash chromatography (25% Et2O in hexanes). 93% ee, 
[α]D25 –50.9 (c 0.67, CHCl3); Rf = 0.4 (25% Et2O in hexanes); 1H NMR (400 MHz, 
CDCl3) δ 7.43 – 7.29 (m, 4H), 7.26 – 7.19 (m, 1H), 6.50 (dd, J = 15.8, 1.3 Hz, 1H), 6.14 
(ddd, J = 15.7, 8.1, 6.6 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.45 (ddt, J = 9.3, 6.5, 3.4 Hz, 
1H), 3.28 (dt, J = 13.8, 3.2 Hz, 1H), 3.02 (dd, J = 13.9, 3.5 Hz, 1H), 2.96 – 2.79 (m, 2H), 
2.79 – 2.62 (m, 3H), 2.54 (ddd, J = 14.0, 12.4, 4.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ 165.8, 165.7, 160.5, 137.4, 132.7, 128.6, 127.3, 127.0, 126.2, 124.1, 52.4,4 52.43, 39.6, 
34.7, 33.9, 30.4, 29.0.  IR (Neat Film, NaCl) 3024, 2950, 2905, 2841, 1727, 1626, 1599, 
1494, 1434, 1255, 1231, 1208, 1146, 1061, 1022, 967, 930, 745 cm–1; HRMS (MM: ESI-
APCI+) calc’d for C19H23O4S [M+H]+: 347.1312, found 347.1303.  SFC conditions: 10% 
IPA, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): major = 2.75, minor = 2.92. 
  
Dimethyl (S)-2-(1-benzyl-3-cinnamylpiperidin-4-ylidene)malonate 5fa: The General 
Procedure A was followed.  To a 2 dram scintillation vial equipped with a magnetic 
stirring bar was added [Ir(cod)Cl]2 (2.7 mg, 0.004 mmol, 2 mol%), ligand L6 (4.9 mg, 
0.008 mmol, 4 mol%), and TBD (2.8 mg, 0.02 mmol, 10 mol%).  The vial was then 
N
Bn
CO2MeMeO2C
Ph
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charged with THF (1 mL) and stirred at 20 °C for 10 min, generating a light brown 
solution.  To another 2 dram scintillation vial equipped with a magnetic stirring bar was 
charged with LiOt-Bu (19.2 mg, 0.24 mmol, 1.2 equiv), dimethyl 2-(1-benzylpiperidin-4-
ylidene)malonate 1f (60.6 mg, 0.20 mmol, 1.0 equiv), cinnamyl carbonate 2a (76.8 mg, 
0.4 mmol, 2.0 equiv), and 1 mL of THF.  After the transformation of above prepared 
catalyst solution by syringe, the vial was sealed and stirred at 20 °C for 12 h.  Then the 
vial was removed from the glovebox, uncapped, and THF was evaporated under reduced 
pressure.  EtOAc was added to the crude mixture and the resulting precipitate was filtered 
through a silica pad, rinsed with EtOAc and the filtrate was concentrated under reduced 
pressure. The regioselectivity (branched product to linear product: b:l) was determined by 
1H NMR of this crude mixture as >20:1.  The mixture was recovered from NMR tube, 
concentrated, and dried under vacuum.  Then this crude mixture was dissolved in 2 mL of 
toluene and stirred at 100 ºC for 5 h.  After the evaporation of toluene under reduced 
pressure, the desired product 5fa (79.2 mg, 95% yield) was obtained as a yellow oil after 
purification by silica gel flash chromatography (15% EtOAc in hexanes). 95% ee, [α]D25 
–26.1 (c 1.18, CHCl3); Rf = 0.2 (25% Et2O in hexanes); 1H NMR (400 MHz, CDCl3) δ 
7.39 – 7.29 (m, 4H), 7.29 – 7.22 (m, 5H), 7.21 – 7.15 (m, 1H), 6.31 (dt, J = 15.8, 1.3 Hz, 
1H), 6.06 (ddd, J = 15.4, 8.1, 6.8 Hz, 1H), 3.76 (s, 3H), 3.71 (s, 3H), 3.57 (d, J = 13.1 Hz, 
1H), 3.37 (d, J = 13.1 Hz, 1H), 3.14 – 2.94 (m, 3H), 2.91 (dt, J = 11.6, 2.2 Hz, 1H), 2.80 
– 2.67 (m, 1H), 2.62 – 2.45 (m, 2H), 2.12 (ddd, J = 23.7, 11.2, 3.1 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) δ 166.0, 165.9, 161.2, 138.7, 137.6, 132.0, 129.0, 128.5, 128.4, 128.0, 
127.2, 127.1, 126.2, 122.6, 62.5, 55.8, 54.4, 52.3, 52.2, 40.8, 35.8, 28.5.  IR (Neat Film, 
NaCl) 3026, 2949, 2802, 1737, 1732, 1722, 1716, 1633, 1494, 1434, 1366, 1348, 1300, 
1226, 1066, 1038, 1009, 966, 745 cm–1; HRMS (MM: ESI-APCI+) calc’d for C26H30NO4 
[M+H]+: 420.2169, found 420.2172.  SFC conditions: 10% IPA, 2.5 mL/min, Chiralpak 
IC column, λ = 254 nm, tR (min): major = 6.64, minor = 7.42. 
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General Procedure for the Synthesis of Cyclic Alkylidene Malonates. 
 
A known procedure was followed with a slight modification:4 A flame-dried flask 
containing 25 mL of THF chilled with an ice bath was treated with TiCl4 (13.5 mmol, 3 
equiv.) slowly via syringe.  To the resulting yellow solution was added dropwise a 
mixture of ketone (4.5 mmol), dimethyl malonate (13.5 mmol, 3 equiv), pyridine (13.5 
mmol, 3 equiv) in THF (8 mL) and the reaction mixture was allowed to slowly warm to 
room temperature.  Upon completion, as determined by TLC, the reaction was quenched 
by slow addition of water until a homogenous solution was obtained.  THF was then 
removed in vacuo and the resulting aqueous solution was extracted with EtOAc.  The 
combined organic layers were sequentially washed with 1 M HCl and brine, and then 
dried over Na2SO4.  The crude residue was purified by silica gel flash chromatography to 
afford the desired product. 
 
Dimethyl 2-cycloheptylidenemalonate (1a).  
Colorless oil, 45% yield, Rf = 0.4 (15% EtOAc in hexanes), purified by silica gel flash 
chromatography (6% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 3.76 (s, 6H), 
2.65 – 2.58 (m, 4H), 1.70 (dt, J = 4.3, 2.3 Hz, 4H), 1.55 – 1.51 (m, 4H); 13C NMR (125 
MHz, CDCl3) δ 166.1, 165.2, 123.4, 52.0, 34.1, 28.9, 26.6; IR (Neat Film, NaCl) 2926.3, 
2856.8, 1729.0, 1622.0, 1435.3, 1275.5, 1234.1, 1194.3, 1169.8, 1150.3, 1103.5, 1074.1, 
1037.7, 1023.5, 941.5, 749.6 cm–1; HRMS (FAB+) m/z calc’d for C12H19O4 [M+H]+: 
227.1283, found 227.1273. 
 
 
 
O
+ MeO2C CO2Me
TiCl4
pyridine
THF
0 → 25 °C
MeO2C CO2Me
CO2MeMeO2C
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Dimethyl 2-(tetrahydro-4H-pyran-4-ylidene)malonate (1d). 
Colorless oil, 42% yield Rf = 0.2 (15% EtOAc in hexanes), purified by silica gel flash 
chromatography (10% EtOAc in hexanes); 1H NMR (300 MHz, CDCl3) δ 3.80 – 3.76 (m, 
10H), 2.68 (t, J = 5.5 Hz, 4H); 13C NMR (125 MHz, CDCl3) δ 165.7, 156.4, 122.5, 68.3, 
52.3, 33.0; IR (Neat Film, NaCl) 2955.2, 2914.9, 2849.5, 1726.3, 1639.6, 1634.0, 1435.2, 
1382.8, 1357.7, 1295.0, 1259.1, 1242.4, 1205.3, 1097.7, 1061.6, 1031.0, 1005.6, 982.5, 
947.1, 912.4, 838.8, 765.5 cm–1; HRMS (MM: ESI-APCI+) m/z calc’d for C10H14O5 
[M+H]+: 215.0914, found 215.0907.  
 
 
Dimethyl 2-(tetrahydro-4H-thiopyran-4-ylidene)malonate (1e).  
Colorless oil, 83% yield Rf = 0.4 (25% Et2O in hexanes), purified by silica gel flash 
chromatography (25% Et2O in hexanes); 1H NMR (400 MHz, CDCl3) δ 3.76 (d, J = 0.7 
Hz, 6H), 2.96 – 2.83 (m, 4H), 2.83 – 2.70 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 165.7, 
158.5, 123.4, 52.4, 34.5, 30.8; IR (Neat Film, NaCl) 3000, 2951, 2915, 2841, 1725, 1633, 
1434, 1321, 1294, 1256, 1228, 1203, 1168, 1060, 1031, 1007, 973, 942 cm–1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C10H15SO4 [M+H]+: 231.0686, found 231.0684. 	
 
 
Dimethyl 2-(1-benzylpiperidin-4-ylidene)malonate (1f)  
Yellow oil, 56% yield Rf = 0.2 (25% EtOAc in hexanes), purified by silica gel flash 
chromatography (25% EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 7.36 – 7.21 (m, 
5H), 3.75 (s, 6H), 3.52 (s, 2H), 2.67 (d, J = 5.7 Hz, 4H), 2.56 (t, J = 5.6 Hz, 4H); 13C 
O
MeO2C CO2Me
OMe
O
MeO
O
S
OMe
O
MeO
O
N
Bn
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NMR (100 MHz, CDCl3) δ 166.0, 158.9, 138.1, 129.2, 128.4, 127.3, 122.1, 62.5, 54.0, 
52.3, 31.9.		IR (Neat Film, NaCl) 2951, 1907, 2801, 2760, 1732, 1639, 1634, 1494, 1435, 
1365, 1347, 1295, 1254, 1231, 1208, 1144, 1063, 1033, 997 cm–1; HRMS (MM: ESI-
APCI+) m/z calc’d for C17H22NO4 [M+H]+: 304.1543, found 304.1545. 	
 
Determination of the Absolute Configuration of 5aa. 
    The absolute configuration of 5aa was assigned by the X-ray analysis of reduced 
product S5aa. 
 
	
To a flame-dried flask was added malonate 5aa (258.0 mg, 0.75 mmol) and 
CH2Cl2 (30 mL).  The solution was cooled to –78 ºC and DIBAL (neat, 0.8 mL, 4.5 
mmol, 6 equiv) was added slowly via syringe.  The mixture was stirred at –78 ºC for 1 h 
and then room temperature overnight.  The reaction was quenched with saturated 
Rochelle’s salt at 0 ºC, and stirred until two clear phases were obtained. The aqueous 
layer was partitioned with 60 mL of EtOAc, and the combined organic phase was washed 
with brine, dried over Na2SO4, filtered and concentrated.  The crude mixture was then 
filtered though a silica pad, and the resulting solid obtained was purified by 
recrystallization with Et2O/hexanes, affording the desired product S5aa (163.2 mg, 76% 
yield) as colorless crystals. >99% ee, [α]D25 –85.2 (c 1.31, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 7.39 – 7.28 (m, 4H), 7.25 – 7.14 (m, 1H), 6.36 (d, J = 15.9 Hz, 1H), 6.19 (dt, J 
= 15.8, 7.4 Hz, 1H), 4.51 – 4.27 (m, 4H), 2.92 – 2.85 (m, 1H), 2.53 (ddd, J = 12.6, 6.0, 
1.9 Hz, 1H), 2.35 – 2.14 (m, 2H), 2.09 – 1.86 (m, 5H), 1.86 – 1.68 (m, 2H), 1.39 – 1.03 
(m, 4H); 13C NMR (100 MHz, CDCl3) δ 145.6, 137.5, 132.5, 131.4, 128.8, 128.7, 127.2, 
126.1, 62.5, 61.8, 41.5, 40.0, 33.1, 31.1, 30.6, 26.8, 26.0; IR (Neat Film, NaCl) 3349, 
2921, 2851, 1643, 1597, 1493, 1447, 1352, 1231, 1046, 998, 965, 745, 692 cm-1; HRMS 
(MM: ESI-APCI+) m/z calc’d for C19H25O [M–H2O+H]+: 269.1900, found 269.1896; 
OMe
O
MeO
O
Ph
5aa
>99% ee
DIBAL (6 equiv)
CH2Cl2
–78→25 ºC
HO OH
Ph
S5aa
>99% ee
(X-ray)
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SFC conditions: 20% IPA, 2.5 mL/min, Chiralpak IC column, λ = 254 nm, tR (min): 
minor = 6.98, major = 8.97. 
 
General Procedure for the Ir-Catalyzed Asymmetric Allylic Alkylation of  
Endocyclic α ,β-Unsaturated  β−Ketoesters 
Please note that the absolute configuration was determined only for the major isomer of 
compound 7ca (vide infra).  The absolute configuration for all other products 7 has been 
inferred by analogy.  For respective SFC conditions, please refer to Table S2.  Isolated 
yields are given in Scheme 4 (see manuscript). 	
		
In a nitrogen-filled glove box, [Ir(cod)Cl]2 (2.69 mg, 0.004 mmol, 2 mol %), ligand L1 
(3.71 mg, 0.008 mmol, 4 mol %), and TBD (2.78 mg, 0.02 mmol, 10 mol %) were added 
to a 2 dram scintillation vial equipped with a magnetic stirring bar. The vial was then 
charged with THF (1 mL) and stirred at 25 °C for 10 min. To a 20 mL scintillation vial 
was added α,β-unsaturated β–ketoester (0.4 mmol, 2.0 eq), cinnamyl carbonate 2a (38.4 
mg, 0.2 mmol, 1.0 equiv) and 1 mL of THF, then the above pre-formed catalyst solution 
was transferred to this vial. The vial was sealed and stirred at 25 °C for 1 day. The 
reaction mixture was filtered through a pad of silica gel, rinsed with hexane/ethyl acetate 
(5:1, v/v), and concentrated under reduced pressure. The residue was purified by silica 
gel flash chromatography and preparative HPLC. 
 
 
 
 
 
 
Ar OCO2Me
+
[Ir(cod)Cl]2 (2 mol %)
L1 (4 mol %)6
2 7 (b) 8 (l)
X
O
CO2R
X
PhO
CO2R
Ph
X
O
OR
O
n
n n
+
TBD (10 mol %)
THF, 20 °C, 24 h
X = CH2, NBn; n = 1, 2
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Methyl (S)-7-oxo-1-((R)-1-phenylallyl)cyclohept-2-ene-1-carboxylate (7aa) and 
methyl (R)-7-oxo-1-((R)-1-phenylallyl)cyclohept-2-ene-1-carboxylate (7aa’). 
Products 7aa and 7aa’ were isolated by silica gel chromatography (3% EtOAc in 
hexanes) as a mixture of diastereomers (2:1), where were separated by preparative HPLC 
(3% EtOAc in hexanes).   
 
 
The major diastereomer was isolated as a colorless oil, 95% ee, [α]D25 –15.4 (c 1.79, 
CHCl3); Rf = 0.2 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.35 – 7.28 (m, 
2H), 7.25 – 7.15 (m, 3H), 6.22 (ddd, J = 16.7, 10.3, 9.1 Hz, 1H), 6.04 – 5.91 (m, 2H), 
5.15–5.04 (m, 2H), 4.39 (d, J = 9.1 Hz, 1H), 3.68 (s, 3H), 2.71 (dt, J = 12.6, 7.5 Hz, 1H), 
2.28 (dt, J = 12.5, 6.2 Hz, 1H), 1.98 – 1.87 (m, 1H), 1.73 – 1.61 (m, 2H), 1.48 – 1.37 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 205.8, 170.4, 139.1, 137.0, 132.3, 130.5, 127.8, 
127.0, 126.1, 117.8, 71.3, 54.3, 52.9, 40.4, 25.3, 22.9; IR (Neat Film, NaCl) 3030, 2948, 
2359, 2341, 1738, 1716, 1493, 1453, 1433, 1296, 1226, 1194, 1123, 1056 cm–1; HRMS 
(FAB+) m/z calc’d for C18H21O3 [M+H]+: 285.1491, found 285.1496; SFC conditions: 
5% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.99, 
major = 7.08. 
 
 
The minor diastereomer was isolated as a colorless oil, 88% ee, [α]D25 –75.1 (c 0.61, 
CHCl3); Rf = 0.2 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.31 – 7.16 (m, 
5H), 6.20 (ddd, J = 17.0, 10.2, 8.4 Hz, 1H), 6.12 – 6.01 (m, 2H), 5.22 – 5.10 (m, 2H), 
4.38 (d, J = 8.5 Hz, 1H), 3.50 (s, 3H), 2.79 (ddd, J = 12.7, 8.8, 7.2 Hz, 1H), 2.39 (ddd, J = 
12.7, 6.5, 5.1 Hz, 1H), 2.16 – 1.98 (m, 2H), 1.96–1.85 (m, 1H), 1.85 – 1.71 (m, 1H); 13C 
NMR (125 MHz, CDCl3) δ 205.7, 170.0, 139.5, 137.1, 131.7, 129.6, 128.2, 127.2, 126.2, 
118.5, 70.6, 53.3, 52.7, 40.0, 25.2, 23.5; IR (Neat Film, NaCl) 3030, 2948, 1737, 1719, 
1493, 1453, 1434, 1296, 1230, 1194, 1121 cm–1; HRMS (FAB+) m/z calc’d for C18H21O3 
PhO
CO2Me2
7aa
PhO
CO2Me2
7aa'
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[M+H]+: 285.1491, found 285.1498; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 210 nm, tR (min): major = 5.62, minor = 7.98. 
 
 
Methyl (S,Z)-8-oxo-1-((R)-1-phenylallyl)cyclooct-2-ene-1-carboxylate (7ba) and 
methyl (R,Z)-8-oxo-1-((R)-1-phenylallyl)cyclooct-2-ene-1-carboxylate (7ba’). 
 
Products 7ba and 7ba’ were isolated by silica gel chromatography (2% EtOAc in 
hexanes) as a mixture of diastereomers (3:1), where were separated by preparative HPLC 
(3% EtOAc in hexanes).   
 
The major diastereomer was isolated as a colorless oil, 90% ee, [α]D25 +59.3 (c 1.60, 
CHCl3); Rf = 0.4 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.44 – 7.38 (m, 
2H), 7.24 – 7.18 (m, 2H), 7.18 – 7.11 (m, 1H), 6.15 (dt, J = 16.8, 10.1 Hz, 1H), 6.08 (dd, 
J = 11.4, 1.0 Hz, 1H), 5.87 – 5.76 (m, 1H), 5.14 – 5.03 (m, 2H), 4.46 (d, J = 10.1 Hz, 
1H), 3.68 (s, 3H), 2.63 – 2.52 (m, 1H), 2.23 – 2.13 (m, 1H), 1.80 – 1.69 (m, 2H), 1.49 – 
1.37 (m, 2H), 1.20 – 1.07 (m, 1H), 0.66 – 0.55 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 
208.5, 169.8, 139.1, 137.4, 135.4, 131.0, 127.5, 126.7, 124.7, 117.2, 70.8, 53.7, 53.0, 
39.0, 27.6, 25.4, 24.8; IR (Neat Film, NaCl) 3029, 2931, 2859, 1740, 1712, 1492, 1453, 
1432, 1331, 1224, 1176, 1123, 1061 cm–1; HRMS (FAB+) m/z calc’d for C19H23O3 
[M+H]+: 299.1647, found 299.1645; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak IA 
column, λ = 210 nm, tR (min): minor = 4.52, major = 6.36. 
 
 
The minor diastereomer was isolated as a colorless oil, 77% ee, [α]D25 –114.2 (c 0.52, 
CHCl3); Rf = 0.4 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.15 (m, 
5H), 6.17 – 6.02 (m, 2H), 6.01 – 5.91 (m, 1H), 5.29 (ddd, J = 17.0, 1.9, 0.9 Hz, 1H), 5.11 
(ddd, J = 10.1, 1.8, 0.7 Hz, 1H), 4.43 (d, J = 8.9 Hz, 1H), 3.49 (s, 3H), 2.66 (td, J = 12.2, 
2.5 Hz, 1H), 2.25 (ddd, J = 12.3, 7.0, 2.6 Hz, 1H), 2.05 – 1.81 (m, 3H), 1.74 – 1.53 (m, 
PhO
CO2Me3
7ba
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CO2Me3
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2H), 1.31 – 1.21 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 208.2, 169.5, 140.0, 137.0, 
134.0, 129.3, 128.3, 127.1, 124.9, 118.1, 69.5, 52.8, 52.7, 39.2, 27.6, 26.0, 25.3; IR (Neat 
Film, NaCl) 3028, 2931, 2859, 1740, 1715, 1491, 1453, 1432, 1228, 1177, 1432, 1228, 
1177, 1133, 1059 cm–1; HRMS (FAB+) m/z calc’d for C19H23O3 [M+H]+: 299.1647, 
found 299.1654; SFC conditions: 5% IPA, 2.5 mL/min, Chiralpak IA column, λ = 210 
nm, tR (min): major = 5.79, minor = 7.41. 
 
Ethyl (S)-6-oxo-1-((R)-1-phenylallyl)cyclohex-2-ene-1-carboxylate (7ca) and Ethyl 
(R)-6-oxo-1-((R)-1-phenylallyl)cyclohex-2-ene-1-carboxylate (7ca’). 
Products 7ca and 7ca’ were isolated by silica gel chromatography (3% EtOAc in 
hexanes) as a mixture of diastereomers (5:1), where were separated by preparative HPLC 
(4% EtOAc in hexanes).   
 
The major diastereomer was isolated as a colorless oil, 98% ee, [α]D25 –35.8 (c 0.71, 
CHCl3); Rf = 0.2 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.14 (m, 
5H), 6.25 – 6.16 (m, 1H), 6.17 – 6.11 (m, 1H), 6.05 (ddd, J = 10.1, 1.9, 1.3 Hz, 1H), 5.23 
– 5.10 (m, 2H), 4.49 (dt, J = 8.2, 1.2 Hz, 1H), 4.16 (qd, J = 7.1, 2.2 Hz, 2H), 2.37 – 2.23 
(m, 2H), 1.94 – 1.76 (m, 2H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
205.9, 169.3, 138.8, 136.4, 130.5, 130.3, 128.1, 127.1, 126.1, 118.5, 65.6, 62.0, 54.4, 
38.3, 24.5, 14.2; IR (Neat Film, NaCl) 3033, 2980, 1743, 1719, 1493, 1454, 1416, 1391, 
1365, 1342, 1299, 1213, 1165, 1130, 1096, 1044, 1016 cm–1; HRMS (MM: ESI-APCI+) 
m/z calc’d for C18H21O3 [M+H]+: 285.1485, found 285.1482; SFC conditions: 2% IPA, 
3.0 mL/min, Chiralpak IA column, λ = 210 nm, tR (min): minor = 6.82, major = 13.26. 
 
 
The minor diastereomer was isolated as a colorless oil, 91% ee, [α]D25 +28.9 (c 0.30, 
CHCl3); Rf = 0.2 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.30 – 7.16 (m, 
PhO
CO2Et
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5H), 6.29 – 6.18 (m, 1H), 6.15 – 6.07 (m, 1H), 5.94 (ddd, J = 10.0, 2.4, 1.0 Hz, 1H), 5.15 
– 5.07 (m, 2H), 4.34 (d, J = 9.0 Hz, 1H), 4.03 (q, J = 7.1 Hz, 2H), 2.60 – 2.49 (m, 1H), 
2.47 – 2.34 (m, 2H), 2.29–2.17 (m, 1H), 1.14 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) δ 205.6, 169.2, 139.2, 136.8, 130.0, 129.7, 128.2, 127.4, 127.2, 118.2, 65.0, 61.9, 
54.5, 39.2, 24.8, 14.0; IR (Neat Film, NaCl) 3032, 2980, 2931, 1736, 1719, 1637, 1601, 
1493, 1453, 1444, 1419, 1389, 1365, 1342, 1298, 1218, 1166, 1118, 1097, 1045, 1018 
cm–1; HRMS (MM: ESI-APCI+) m/z calc’d for C18H21O3 [M+H]+: 285.1485, found 
285.1480; SFC conditions: 2% IPA, 3.0 mL/min, Chiralpak IA column, λ = 210 nm, tR 
(min): major = 6.95, minor = 11.43. 
 
Methyl (R)-1-benzyl-2-oxo-3-((R)-1-phenylallyl)-2,3,6,7-tetrahydro-1H-azepine-3-
carboxylate (7da) and methyl (S)-1-benzyl-2-oxo-3-((R)-1-phenylallyl)-2,3,6,7-
tetrahydro-1H-azepine-3-carboxylate (7da’). 
Products 7da and 7da’ were isolated by silica gel chromatography (3% EtOAc in 
hexanes) as a mixture of diastereomers (2:1), where were separated by preparative HPLC 
(12% EtOAc in hexanes).   
 
The major diastereomer was isolated as a colorless oil, 79% ee, [α]D25 –14.6 (c 0.19, 
CHCl3); Rf = 0.4 (25% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.19 
(m, 10H), 6.27 (ddd, J = 17.3, 10.6, 5.4 Hz, 1H), 5.99 – 5.90 (m, 2H), 5.24 (dt, J = 10.6, 
1.7 Hz, 1H), 5.09 (d, J = 14.9 Hz, 1H), 5.02 (dt, J = 17.3, 1.7 Hz, 1H), 4.74 (dt, J = 5.4, 
1.9 Hz, 1H), 4.34 (d, J = 14.9 Hz, 1H), 3.54 – 3.44 (m, 1H), 3.39 (s, 3H), 3.09 – 3.00 (m, 
1H), 2.26 – 2.07 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 171.7, 170.7, 139.3, 138.9, 
137.7, 132.0, 130.4, 128.7, 128.3, 127.9, 127.5, 127.4, 124.7, 118.1, 62.3, 54.7, 52.4, 
51.4, 44.0, 28.3; IR (Neat Film, NaCl) 3029, 2048, 1737, 1728, 1656, 1652, 1495, 1480, 
1431, 1416, 1357, 1242, 1227, 1164, 1045,1001 cm–1; HRMS (MM: ESI-APCI+) m/z 
calc’d for C24H26NO3 [M+H]+: 376.1907, found 376.1917; SFC conditions: 10% MeCN, 
2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): minor = 13.74, major = 
16.85. 
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The minor diastereomer was isolated as a colorless oil, 62% ee, [α]D25 –42.3 (c 0.12, 
CHCl3); Rf = 0.4 (25% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.49 – 7.42 
(m, 2H), 7.36 – 7.16 (m, 8H), 6.40 (ddd, J = 16.9, 10.1, 9.1 Hz, 1H), 5.88 (dddd, J = 11.8, 
4.7, 3.1, 1.3 Hz, 1H), 5.73 (dt, J = 11.9, 2.2 Hz, 1H), 5.23 – 5.05 (m, 2H), 4.99 (d, J = 
14.8 Hz, 1H), 4.45 (d, J = 9.1 Hz, 1H), 4.32 (d, J = 14.9 Hz, 1H), 3.63 (s, 3H), 3.51 – 
3.42 (m, 1H), 3.10 – 3.02 (m, 1H), 2.22 – 2.04 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 
172.0, 170.3, 140.2, 137.7, 137.7, 131.1, 130.3, 128.7, 128.0, 127.9, 127.5, 126.7, 126.2, 
118.2, 63.1, 56.6, 52.7, 51.4, 44.2, 28.2; IR (Neat Film, NaCl) 3028, 2948, 1732, 1656, 
1652, 1495, 1480, 1429, 1417, 1357, 1241, 1226, 1163, 1044, 1002 cm–1; HRMS (MM: 
ESI-APCI+) m/z calc’d for C24H26NO3 [M+H]+: 376.1907, found 376.1915; SFC 
conditions: 10% MeCN, 2.5 mL/min, Chiralcel OD-H column, λ = 210 nm, tR (min): 
major = 12.34, minor = 15.02. 
 
Methyl (S)-7-oxo-1-((R)-1-(p-tolyl)allyl)cyclohept-2-ene-1-carboxylate (7ab) and 
methyl (R)-7-oxo-1-((R)-1-(p-tolyl)allyl)cyclohept-2-ene-1-carboxylate (7ab’). 
 
Products 7ab and 7ab’ were isolated by silica gel chromatography (2% EtOAc in 
hexanes) as a mixture of diastereomers (1.2:1), where were separated by preparative 
HPLC (3% EtOAc in hexanes).   
 
The major diastereomer was isolated as a colorless oil, 95% ee, [α]D25 –17.5 (c 0.195, 
CHCl3); Rf = 0.3 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.19 (d, J = 8.1 
Hz, 2H), 7.03 (d, J = 7.7 Hz, 2H), 6.21 (ddd, J = 16.7, 10.4, 9.1 Hz, 1H), 6.00 – 5.90 (m, 
2H), 5.13 – 5.04 (m, 2H), 4.33 (d, J = 9.0 Hz, 1H), 3.69 (s, 3H), 2.71 (dt, J = 12.7, 7.3 
Hz, 1H), 2.36 – 2.25 (m, 4H), 2.01 – 1.89 (m, 1H), 1.73 – 1.62 (m, 2H), 1.56 – 1.43 (m, 
1H); 13C NMR (125 MHz, CDCl3) δ 205.9, 170.5, 137.2, 136.6, 136.1, 132.3, 130.2, 
BnN
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128.6, 126.2, 117.6, 71.1, 54.0, 52.9, 40.6, 25.6, 22.9, 21.2; IR (Neat Film, NaCl) 2948, 
1738, 1716, 1514, 1435, 1225, 1123 cm–1; HRMS (FAB+) m/z calc’d for C19H23O3 
[M+H]+: 299.1647, found 299.1655; SFC conditions: 8% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 210 nm, tR (min): minor = 4.13, major = 4.50. 
 
 
The minor diastereomer was isolated as a colorless oil, 91% ee, [α]D25 –76.0 (c 0.17, 
CHCl3); Rf = 0.3 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.13 – 7.00 (m, 
4H), 6.17 (ddd, J = 17.0, 10.2, 8.5 Hz, 1H), 6.11 – 6.00 (m, 2H), 5.17 (ddd, J = 17.0, 1.8, 
1.0 Hz, 1H), 5.12 (ddd, J = 10.2, 1.8, 0.8 Hz, 1H), 4.35 (d, J = 8.5 Hz, 1H), 3.52 (s, 3H), 
2.79 (ddd, J = 12.7, 8.7, 7.1 Hz, 1H), 2.39 (ddd, J = 12.6, 6.4, 5.2 Hz, 1H), 2.30 (s, 3H), 
2.17 – 2.00 (m, 2H), 1.96 – 1.85 (m, 1H), 1.85 – 1.73 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 205.8, 170.0, 137.2, 136.7, 136.4, 131.6, 129.3, 129.0, 126.3, 118.2, 70.6, 52.9, 
52.7, 40.0, 25.2, 23.5, 21.2; IR (Neat Film, NaCl) 2948, 1736, 1720, 1716, 1513, 1435, 
1230, 1194, 1123 cm–1; HRMS (FAB+) m/z calc’d for C19H23O3 [M+H]+: 299.1647, 
found 299.1640; SFC conditions: 10% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 
210 nm, tR (min): minor = 3.43, major = 4.49. 
 
 
Methyl (S)-1-((R)-1-(3-methoxyphenyl)allyl)-7-oxocyclohept-2-ene-1-carboxylate 
(7ad) and methyl (R)-1-((R)-1-(3-methoxyphenyl)allyl)-7-oxocyclohept-2-ene-1-
carboxylate (7ad’) 
 
Products 7ba and 7ba’ were isolated by silica gel chromatography (2% EtOAc in 
hexanes) as a mixture of diastereomers (2:1), where were separated by preparative HPLC 
(7% EtOAc in hexanes).   
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The major diastereomer was isolated as a colorless oil, 91% ee, [α]D25 –14.9 (c 0.29, 
CHCl3); Rf = 0.3 (17% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.14 (t, J = 8.1 
Hz, 1H), 6.93 – 6.87 (m, 2H), 6.74 (ddd, J = 8.2, 2.5, 1.1 Hz, 1H), 6.26 – 6.14 (m, 1H), 
6.02 – 5.91 (m, 2H), 5.15 – 5.06 (m, 2H), 4.35 (d, J = 9.1 Hz, 1H), 3.78 (s, 3H), 3.69 (s, 
3H), 2.71 (dt, J = 12.7, 7.3 Hz, 1H), 2.30 (dt, J = 12.6, 6.2 Hz, 1H), 2.04 – 1.92 (m, 1H), 
1.74 – 1.63 (m, 2H), 1.56 – 1.47 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 205.7, 170.4, 
159.0, 140.7, 136.9, 132.3, 128.8, 126.2, 122.8, 117.9, 116.2, 112.4, 71.1, 55.3, 54.4, 
52.9, 40.5, 25.6, 22.8; IR (Neat Film, NaCl) 2949, 1738, 1716, 1599, 1583, 1489, 1455, 
1435, 1225, 1050 cm–1; HRMS (FAB+) m/z calc’d for C19H23O4 [M+H]+: 315.1596, found 
315.1592; SFC conditions: 8% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, 
tR (min): minor = 4.28, major = 4.75. 
 
 
The minor diastereomer was isolated as a colorless oil, 81% ee, [α]D25 –64.5 (c 0.135, 
CHCl3); Rf = 0.3 (17% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.17 (t, J = 7.9 
Hz, 1H), 6.84 – 6.71 (m, 3H), 6.15 (ddd, J = 17.0, 10.2, 8.6 Hz, 1H), 6.11 – 6.02 (m, 2H), 
5.21 (ddd, J = 17.1, 1.8, 1.0 Hz, 1H), 5.13 (ddd, J = 10.2, 1.7, 0.8 Hz, 1H), 4.37 (d, J = 
8.6 Hz, 1H), 3.78 (s, 3H), 3.53 (s, 3H), 2.79 (ddd, J = 12.5, 8.8, 7.3 Hz, 1H), 2.39 (ddd, J 
= 12.4, 6.6, 4.9 Hz, 1H), 2.17 – 2.01 (m, 2H), 1.98 – 1.86 (m, 1H), 1.86 – 1.72 (m, 1H); 
13C NMR (125 MHz, CDCl3) δ 205.7, 169.9, 159.3, 141.1, 136.8, 131.5, 129.2, 126.3, 
121.8, 118.5, 115.6, 112.3, 70.7, 55.3, 53.2, 52.7, 39.8, 25.1, 23.6; IR (Neat Film, NaCl) 
2949, 1735, 1719, 1599, 1583, 1491, 1453, 1434, 1230, 1049 cm–1; HRMS (FAB+) m/z 
calc’d for C19H23O4 [M+H]+: 315.1596, found 315.1603; SFC conditions: 10% IPA, 2.5 
mL/min, Chiralpak IC column, λ = 210 nm, tR (min): minor = 5.40, major = 5.99. 
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Methyl (S)-1-((R)-1-(3-chlorophenyl)allyl)-7-oxocyclohept-2-ene-1-carboxylate (7ae) 
and methyl (R)-1-((R)-1-(3-chlorophenyl)allyl)-7-oxocyclohept-2-ene-1-carboxylate 
(7ae’) 
Products 7ae and 7ae’ were isolated by silica gel chromatography (2% EtOAc in 
hexanes) as a mixture of diastereomers (3:1), where were separated by preparative HPLC 
(3.5% EtOAc in hexanes).   
 
The major diastereomer was isolated as a colorless oil, 91% ee, [α]D25 –4.9 (c 0.325, 
CHCl3); Rf = 0.4 (17% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.34 – 7.28 (m, 
1H), 7.25 – 7.20 (m, 1H), 7.18 – 7.14 (m, 2H), 6.15 (ddd, J = 16.8, 10.2, 9.2 Hz, 1H), 
6.05–5.93 (m, 2H), 5.16 – 5.06 (m, 2H), 4.35 (d, J = 9.2 Hz, 1H), 3.69 (s, 3H), 2.74 (ddd, 
J = 12.6, 8.0, 7.4 Hz, 1H), 2.31 (dt, J = 12.5, 6.0 Hz, 1H), 2.01 – 1.87 (m, 1H), 1.75 – 
1.63 (m, 2H), 1.48 – 1.35 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 205.5, 170.1, 141.3, 
136.3, 133.5, 132.6, 130.4, 129.0, 128.8, 127.1, 125.8, 118.4, 71.2, 53.8, 53.0, 40.2, 25.2, 
22.9; IR (Neat Film, NaCl) 2949, 1738, 1716, 1594, 1571, 1432, 1228, 1195, 1123, 1094 
cm–1; HRMS (FAB+) m/z calc’d for C18H20O3Cl [M+H]+: 319.1101, found 319.1112; SFC 
conditions: 7% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor 
= 4.14, major = 4.85. 
 
 
The minor diastereomer was isolated as a colorless oil, 75% ee, [α]D25 –56.2 (c 0.105, 
CHCl3); Rf = 0.4 (17% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.24 – 7.15 (m, 
3H), 7.15 – 7.08 (m, 1H), 6.15 (ddd, J = 17.0, 10.2, 8.6 Hz, 1H), 6.09 (ddd, J = 11.4, 7.2, 
5.5 Hz, 1H), 5.99 (dd, J = 11.5, 2.1 Hz, 1H), 5.23 – 5.13 (m, 2H), 4.34 (d, J = 8.6 Hz, 
1H), 3.55 (s, 3H), 2.80 (ddd, J = 12.6, 8.8, 7.2 Hz, 1H), 2.40 (ddd, J = 12.7, 6.5, 5.0 Hz, 
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1H), 2.17 – 2.08 (m, 1H), 2.08 – 1.97 (m, 1H), 1.97 – 1.86 (m, 1H), 1.86 – 1.73 (m, 1H); 
13C NMR (125 MHz, CDCl3) δ 205.3, 169.9, 141.7, 136.4, 133.9, 132.1, 129.7, 129.4, 
127.7, 127.4, 125.8, 119.0, 70.4, 53.0, 52.8, 39.9, 25.2, 23.4; IR (Neat Film, NaCl) 2949, 
1738, 1720, 1594, 1571, 1476, 1455, 1432, 1231, 1194, 1121, 1095 cm–1; HRMS (FAB+) 
m/z calc’d for C18H20O3Cl [M+H]+: 319.1101, found 319.1089; SFC conditions: 7% IPA, 
2.5 mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): major = 4.67, minor = 5.28. 		
Methyl (S)-1-((R)-1-(4-bromophenyl)allyl)-7-oxocyclohept-2-ene-1-carboxylate (7af) 
and methyl (R)-1-((R)-1-(4-bromophenyl)allyl)-7-oxocyclohept-2-ene-1-carboxylate 
(7af’) 
 
Products 7af and 7af’ were isolated by silica gel chromatography (2% EtOAc in hexanes) 
as a mixture of diastereomers (2:1), where were separated by preparative HPLC (4% 
EtOAc in hexanes).   
		  
The major diastereomer was isolated as a colorless oil, 88% ee, [α]D25 –20.4 (c 0.31, 
CHCl3); Rf = 0.3 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.5 
Hz, 2H), 7.22 (d, J = 8.4 Hz, 2H), 6.14 (ddd, J = 16.8, 10.2, 9.2 Hz, 1H), 6.03 – 5.93 (m, 
2H), 5.15 – 5.04 (m, 2H), 4.36 (d, J = 9.2 Hz, 1H), 3.68 (s, 3H), 2.73 (ddd, J = 12.5, 8.1, 
7.4 Hz, 1H), 2.29 (dt, J = 12.5, 5.9 Hz, 1H), 1.98 – 1.86 (m, 1H), 1.76 – 1.63 (m, 2H), 
1.47 – 1.33 (m, 1H); 13C NMR (125 MHz, CDCl3) δ 205.7, 170.1, 138.3, 136.4, 132.5, 
132.2, 130.9, 125.9, 121.0, 118.2, 71.3, 53.5, 53.0, 40.06, 25.2, 23.1; IR (Neat Film, 
NaCl) 2948, 1738, 1720, 1716, 1487, 1432, 1227, 1194, 1010 cm–1; HRMS (FAB+) m/z 
calc’d for C18H20BrO3 [M+H]+: 363.0596, found 363.0588; SFC conditions: 10% IPA, 2.5 
mL/min, Chiralpak AD-H column, λ = 210 nm, tR (min): minor = 4.68, major = 5.17. 
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The minor diastereomer was isolated as a colorless oil, 79% ee, [α]D25 –76.3 (c 0.16, 
CHCl3); Rf = 0.3 (9% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.5 
Hz, 2H), 7.11 (d, J = 8.4 Hz, 2H), 6.22 – 6.11 (m, 1H), 6.06 (ddd, J = 11.4, 7.2, 5.4 Hz, 
1H), 5.97 (dd, J = 11.5, 2.1 Hz, 1H), 5.19 – 5.10 (m, 2H), 4.30 (d, J = 8.5 Hz, 1H), 3.54 
(s, 3H), 2.80 (ddd, J = 12.7, 8.7, 7.1 Hz, 1H), 2.40 (ddd, J = 12.7, 6.4, 5.2 Hz, 1H), 2.17 – 
2.07 (m, 1H), 2.04 – 1.94 (m, 1H), 1.94 – 1.85 (m, 1H), 1.84 – 1.73 (m, 1H); 13C NMR 
(125 MHz, CDCl3) δ 205.5, 170.0, 138.6, 136.6, 132.1, 131.4, 131.3, 125.9, 121.2, 118.8, 
70.4, 52.9, 52.8, 40.0, 25.3, 23.3; IR (Neat Film, NaCl) 2948, 1737, 1716, 1488, 1230, 
1194, 1075, 1010 cm–1; HRMS (FAB+) m/z calc’d for C18H20BrO3 [M+H]+: 363.0596, 
found 363.0604; SFC conditions: 10% IPA, 2.5 mL/min, Chiralpak IC column, λ = 210 
nm, tR (min): minor = 4.43, major = 5.01. 
Determination of the Absolute Configuration of 7ca. 
    The absolute configuration of 7ca was determined by comparing the optical rotation of 
its derivative with compound S2 obtained from the previously known compound S1.5 
 
General procedure for the Pd/C-catalyzed hydrogenation (for eq 1): To a round bottom 
flask was added ethyl (R)-2-oxo-1-((S)-1-phenylallyl)cyclohexane-1-carboxylate S1 (42.0 
mg, >99% ee, 0.15 mmol), 10% Pd/C (2.9 mg, 2 mol%) and EtOH (4 mL).  A hydrogen 
O
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7af'
Br
PhO
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S1 S2
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PhO
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balloon was then connected via a three-way stopcock.  The flask was vacuumed/purged 
with H2 quickly three times, then stirred for 2 h at room temperature.  The mixture was 
filtered through a silica pad and the desired product S2 (25.0 mg, 59% yield) was 
obtained as a colorless oil after purification by silica gel flash chromatography (1→5% 
EtOAc in hexanes).  Rf = 0.4 (5% EtOAc in hexanes); [a]D25 +40.84 (c 0.67, CHCl3).  1H 
NMR (500 MHz, CDCl3) δ 7.29 – 7.23 (m, 2H), 7.23 – 7.18 (m, 1H), 7.18 – 7.12 (m, 
2H), 4.21 (qd, J = 7.1, 2.2 Hz, 2H), 3.12 (dd, J = 12.1, 2.8 Hz, 1H), 2.54 – 2.39 (m, 2H), 
1.95 (ddq, J = 19.7, 9.0, 3.1 Hz, 2H), 1.91 – 1.82 (m, 1H), 1.70 – 1.61 (m, 1H), 1.61 – 
1.47 (m, 3H), 1.36 – 1.30 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H), 0.69 (t, J = 7.3 Hz, 3H).  13C 
NMR (125 MHz,	CDCl3) δ 207.9, 171.4, 139.9, 130.4, 127.9, 126.8, 64.6, 61.2, 51.3, 
41.9, 36.9, 28.0, 24.7, 22.9, 14.2, 13.0. 	 IR (Neat Film NaCl) 3026, 2961, 2935, 2870, 
1712, 1495, 1451, 1368, 1308, 1269, 1233, 1194, 1138, 1090, 1025, 908, 865, 812, 759 
cm–1; HRMS (ESI) calc’d for C18H25O3 [M+H]+: 289.1798, found 289.1798.  
For eq 2: Followed the same procedure as eq 1.  The reaction was conducted with 7ba 
(76.4 mg, 0.27 mmol), 10% Pd/C (14.3 mg, 5 mol%) and EtOH (5 mL).  The desired 
hydrogenation product was obtained in 31% yield (24.0 mg) with the same 1H NMR 
spectrum and opposite optical rotation when compared to S2.  
General Procedure for the Cope Rearrangment of β−Ketoesters 7. 	
 A solution of compound 7 in toluene (0.1 M) was heated at 100 °C for five 
hours.  After cooling to room temperature, the reaction mixture was concentrated in 
vacuo.  The residue was purified by silica gel flash chromatography to afford the desired 
product 9. 
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Methyl (R)-3-cinnamyl-7-oxocyclohept-1-ene-1-carboxylate (9aa) 
9aa was isolated by silica gel chromatography (3→9→17% EtOAc in hexanes, 72% 
yield) as a colorless oil. [α]D25 –23.6 (c 0.49, CHCl3); 95% ee; Rf = 0.4 (25% EtOAc in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.28 (m, 4H), 7.27 – 7.18 (m, 2H), 6.46 
(d, J = 15.8 Hz, 1H), 6.15 (dt, J = 15.7, 7.2 Hz, 1H), 3.77 (s, 3H), 2.74 – 2.57 (m, 3H), 
2.54 – 2.34 (m, 2H), 2.00 – 1.80 (m, 3H), 1.56 – 1.48 (m, 1H); 13C NMR (125 MHz, 
CDCl3) δ 203.0, 165.5, 151.9, 137.2, 135.4, 133.1, 128.7, 127.6, 126.8, 126.3, 52.5, 43.3, 
39.6, 39.1, 30.2, 21.5; IR (Neat Film, NaCl) 3024, 2929, 2858, 1722, 1716, 1495, 1435, 
1377, 1256, 1202, 1027 cm–1; HRMS (FAB+) m/z calc’d for C18H21O3 [M+H]+: 285.1491, 
found 285.1491; SFC conditions: 10% IPA, 2.5 mL/min, Chiralcel OB-H column, λ = 
210 nm, tR (min): major = 13.72, minor = 15.18. 
 
Synthesis	of	Endocyclic	α ,β-Unsaturated	β−Ketoesters.  
The α,β-unsaturated β–ketoesters 6a6 and 6c7 were prepared following literature 
procedures. 
 
 
Methyl (E)-8-oxocyclooct-1-ene-1-carboxylate (6b) 
Following a modified literature procedure,8 NaH (60% in mineral oil, 440 mg, 1.1 equiv) 
was added to a 250 mL round bottom flask and flushed with N2.  THF (27 mL) was then 
added, and the resulting suspension cooled to 0 °C.  A solution of methyl 2-
oxocyclooctane-1-carboxylate9 (1.84 g, 10 mmol) in THF (5 mL) was added slowly at 0 
°C, and then the reaction mixture was warmed to room temperature.  After stirring for 1 
h, the enolate solution was cooled to –78 °C and a solution of PhSeCl (2.01 g, 1.05 equiv) 
in THF (8 mL) was added. After stirring for 1 h at –78 °C, the reaction mixture was 
warmed to room temperature and stirred for an additional 1 h. Upon completion, the 
solution was diluted with Et2O and washed twice with 1 M HCl, followed by brine.  The 
organic layer was dried over Na2SO4 and concentrated.  The crude product was dissolved 
in CH2Cl2 (100 mL), cooled to 0 °C, and treated with a solution of H2O2 (35% in water, 
1.84 mL, 2.1 equiv) dropwise over 30 min.  After stirring for an additional 1 h, water was 
added and the aqueous layer extracted with CH2Cl2.  The combined organic layers were 
1. NaH, PhSeCl, –78 °C → rt, THF
2. H2O2, 0 °C, DCM
                        85%
O
CO2Me
O
CO2Me
6b
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washed with saturated NaHCO3, water, brine and dried with Na2SO4.  The crude product 
was purified by silica gel flash chromatography (5→9% EtOAc in hexanes) to provide 6b 
as a colorless oil (1.54 g, 85%). Rf = 0.3 (17% EtOAc in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 7.22 (t, J = 4.7 Hz, 1H), 3.73 (s, 3H), 2.60 – 2.53 (m, 2H), 2.43 – 2.36 (m, 2H), 
1.94 – 1.85 (m, 2H), 1.73 – 1.61 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 209.2, 165.0, 
147.3, 131.3, 52.4, 44.6, 30.4, 29.3, 22.2, 21.8; IR (Neat Film, NaCl) 2946, 1719, 1696, 
1638, 1434, 1411, 1376, 1266, 1237, 1219, 1157, 1068 cm–1; HRMS (FAB+) m/z calc’d 
for C10H14O3 [M+H]+: 183.1021, found 183.1029. 
 
Methyl 1-benzyl-2-oxo-2,5,6,7-tetrahydro-1H-azepine-3-carboxylate (6d) 
To a solution of LDA [1.2 equiv, prepared fresh from diisopropylamine (513 μL) and n-
BuLi, (2.5 M in hexanes, 1.46 mL) in THF (10 mL) at 0 °C for 15 min] was added 
dropwise a solution of methyl 1-benzyl-2-oxoazepane-3-carboxylate (798 mg, 3.05 
mmol) in THF (3 mL) at –78 °C and the resulting mixture was stirred for 1 h at –78 °C. A 
solution of PhSeCl (615 mg, 1.05 equiv) in THF (3 mL) was then added, and the mixture 
was slowly warmed to room temperature.  The mixture was diluted with ethyl acetate, 
washed twice with 1 M HCl, followed by brine, and dried over Na2SO4.  The crude 
mixture was purified by silica gel flash chromatography (9→17→20% EtOAc in 
hexanes) to provide methyl 1-benzyl-2-oxo-3-(phenylselanyl)azepane-3-carboxylate as a 
yellow oil (343 mg, 27%).  The isolated compound was carried forward without complete 
characterization by dissolving in CH2Cl2 (8 mL) and cooling to 0 °C.  A solution of H2O2 
(35% in water, 145 μL, 2.1 equiv) was added dropwise over 30 min.  After stirring for an 
additional 1 h, water was added and the aqueous later extracted with CH2Cl2.  The 
combined organic layers were washed with saturated NaHCO3, water, brine and dried 
with Na2SO4.  The crude product was purified by silica gel flash chromatography (25→
50% EtOAc in hexanes) to provide 9 as a pale yellow oil (170 mg, 79%). Rf = 0.3 (50% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.27 (m, 6H), 4.72 (s, 2H), 
3.83 (s, 3H), 3.30 (t, J = 6.3 Hz, 2H), 2.26 (q, J = 7.4 Hz, 2H), 1.74 – 1.64 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 166.5, 165.1, 143.8, 138.0, 132.4, 128.9, 128.5, 127.8, 52.5, 
1. LDA, PhSeCl,
   –78 °C → rt, 
   THF, 27%
2. H2O2, 0 °C,
    CH2Cl2, 79%
BnN
O
CO2Me
BnN
O
CO2Me
6d
Supporting Information for Liu, Okamoto, Alexy, Hong, Tran, and Stoltz SI 38 
49.8, 45.4, 27.9, 23.7; IR (Neat Film, NaCl) 3493, 3029, 2952, 1721, 1650, 1621, 1471, 
1435, 1359, 1274, 1251, 1193, 1159, 1103, 1067, 1053 cm–1; HRMS (MM: ESI-APCI+) 
m/z calc’d for C15H18NO3 [M+H]+: 260.1281, found 260.1285. 
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Table S2. Determination of Enantiomeric Excess 
  
entry compound SFC analytic conditions ee (%)
1
CO2MeMeO2C
Ph
3aa
Chiralpak AD-H, λ = 210 nm
2% IPA/CO2, 2.5 mL/min
tR (min) minor 7.34, major 8.12
>99
2
Chiralpak AD-H, λ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min) major 4.55, minor 4.88
96
CO2MeMeO2C
Ph
5aa
3
Chiralpak IC, λ = 254 nm
5% IPA/CO2, 2.5 mL/min
tR (min) major 7.54, minor 10.52
96
MeO2C CO2Me
Me
5ab
4
Chiralpak IC, λ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min) major 7.39, minor 9.02
96
MeO2C CO2Me
OMe
5ac
5
Chiralpak IC, λ = 254 nm
5% MeOH/CO2, 2.5 mL/min
tR (min) major 9.50, minor 10.16
97
MeO2C CO2Me
5ad
OMe
6
Chiralpak IC, λ = 254 nm
3% IPA/CO2, 4.0 mL/min
tR (min) major 12.00, minor 17.72
96
MeO2C CO2Me
5ae
Cl
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entry compound SFC analytic conditions ee (%)
7
Chiralpak IC, λ = 254 nm
9% MeOH/CO2, 2.5 mL/min
tR (min) major 5.33, minor 5.85
97
MeO2C CO2Me
Br
5af
8
Chiralpak IC, λ = 254 nm
3% MeOH/CO2, 2.5 mL/min
tR (min) major 11.55, minor 12.69
96
MeO2C CO2Me
5ag
S
CO2MeMeO2C
Ph
9
Chiralcel OJ-H, λ = 254 nm
15% IPA/CO2, 2.5 mL/min
tR (min) minor 2.87, major 4.16
91
5ba
CO2MeMeO2C
Ph
10
Chiralpak AD-H, λ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min) minor 4.41, major 4.79
90
5ca
O
CO2MeMeO2C
Ph
11
Chiralcel OJ-H, λ = 254 nm
15% IPA/CO2, 2.5 mL/min
tR (min) minor 2.79, major 4.44
94
5da
S
CO2MeMeO2C
Ph
12
Chiralpak IC, λ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min) major 2.75, minor 2.92
93
5ea
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entry compound SFC analytic conditions ee (%)
N
Bn
CO2MeMeO2C
Ph
13
Chiralpak IC, λ = 254 nm
10% IPA/CO2, 2.5 mL/min
tR (min) major 6.64, minor 7.42
95
5fa
14
Chiralpak IC, λ = 254 nm
20% IPA/CO2, 2.5 mL/min
tR (min) minor 6.98, major 8.97
>99
S5aa
HO OH
Ph
PhO
CO2Me2
7aa
15
Chiralpak AD-H, λ = 210 nm
5% IPA/CO2, 2.5 mL/min
tR (min) minor 4.99, major 7.08
95
PhO
CO2Me2
7aa'
16
Chiralpak AD-H, λ = 210 nm
5% IPA/CO2, 2.5 mL/min
tR (min) major 5.62, minor 7.98
88
PhO
CO2Me3
7ba
17
Chiralpak IA, λ = 210 nm
5% IPA/CO2, 2.5 mL/min
tR (min) minor 4.52, major 6.36
90
PhO
CO2Me3
7ba'
18
Chiralpak IA, λ = 210 nm
5% IPA/CO2, 2.5 mL/min
tR (min) major 5.79, minor 7.41
77
PhO
CO2Me
7ca
19
Chiralpak IA, λ = 210 nm
2% IPA/CO2, 3.0 mL/min
tR (min) minor 6.82, major 13.26
98
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entry compound SFC analytic conditions ee (%)
PhO
CO2Me
7ca'
20
Chiralpak IA, λ = 210 nm
2% IPA/CO2, 3.0 mL/min
tR (min) major 6.95, minor 11.43
91
BnN
PhO
CO2Me2
7da
21
Chiralcel OD-H, λ = 210 nm
10% MeCN/CO2, 2.5 mL/min
tR (min) minor 13.74, major 16.85
79
O
CO2Me2
7ab
23
Chiralpak AD-H, λ = 210 nm
8% IPA/CO2, 2.5 mL/min
tR (min) minor 4.13, major 4.50
95
BnN
PhO
CO2Me2
7da'
22
Chiralcel OD-H, λ = 210 nm
10% MeCN/CO2, 2.5 mL/min
tR (min) major 12.34, minor 15.02
62
Me
O
CO2Me2
7ab'
24
Chiralpak AD-H, λ = 210 nm
10% IPA/CO2, 2.5 mL/min
tR (min) minor 3.43, major 4.49
91
Me
O
CO2Me2
7ad
25
Chiralpak AD-H, λ = 210 nm
8% IPA/CO2, 2.5 mL/min
tR (min) minor 4.28, major 4.75
91
OMe
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entry compound SFC analytic conditions ee (%)
O
CO2Me2
7ad'
26
Chiralpak IC, λ = 210 nm
10% IPA/CO2, 2.5 mL/min
tR (min) minor 5.40, major 5.99
81
OMe
O
CO2Me2
7ae
27
Chiralpak AD-H, λ = 210 nm
7% IPA/CO2, 2.5 mL/min
tR (min) minor 4.14, major 4.85
91
Cl
O
CO2Me2
7ae'
28
Chiralpak AD-H, λ = 210 nm
7% IPA/CO2, 2.5 mL/min
tR (min) major 4.67, minor 5.28
75
Cl
O
CO2Me2
7af
29
Chiralpak AD-H, λ = 210 nm
10% IPA/CO2, 2.5 mL/min
tR (min) minor 4.68, major 5.17
88
Br
O
CO2Me2
7af'
30
Chiralpak IC, λ = 210 nm
10% IPA/CO2, 2.5 mL/min
tR (min) minor 4.43, major 5.01
79
Br
O
2
31
Chiralcel OB-H, λ = 210 nm
10% IPA/CO2, 2.5 mL/min
tR (min) major 13.72, minor 15.18
95
CO2Me
Ph
9aa
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Crystal Structure Analysis of Alkylation Product 3aa (smaple No.: p15559): 
 
 The α-alkylated Malonate 3aa (>99% ee) was recrystallized from Et2O/hexanes 
(liquid/liquid diffusion) at 0 ºC to provide suitable crystals for X-ray analysis, m.p. = 53 – 
55 ºC (hexanes/Et2O). 
 
	Table 1.  Crystal data and structure refinement for p15559. 
Identification code  p15559 
Empirical formula  C21 H26 O4 
Formula weight  342.42 
Temperature  100 K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.7585(6) ≈ α= 90∞ 
 b = 9.1039(7) ≈ β= 90∞ 
 c = 26.2256(17) ≈ γ = 90∞ 
Volume 1852.4(2) ≈3 
Z 4 
Density (calculated) 1.228 Mg/m3 
Absorption coefficient 0.674 mm-1 
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F(000) 736 
Crystal size 0.21 x 0.19 x 0.17 mm3 
Theta range for data collection 3.370 to 78.511∞. 
Index ranges -9<=h<=9, -11<=k<=11, -32<=l<=33 
Reflections collected 39232 
Independent reflections 3967 [R(int) = 0.0517] 
Completeness to theta = 67.000∞ 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9612 and 0.9073 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3967 / 0 / 228 
Goodness-of-fit on F2 1.078 
Final R indices [I>2sigma(I)] R1 = 0.0402, wR2 = 0.1023 
R indices (all data) R1 = 0.0418, wR2 = 0.1032 
Absolute structure parameter 0.12(7) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.476 and -0.182 e.≈-3 
 
Table 2.  Atomic coordinates  ( x 105) and equivalent  isotropic displacement parameters 
(≈2x 104) for p15559.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
O(1) 47530(20) 48207(19) 71564(6) 265(4) 
O(2) 59320(20) 31380(18) 66418(6) 230(3) 
O(3) 40030(20) 33780(20) 54882(7) 328(4) 
O(4) 64670(20) 44547(18) 57227(6) 219(3) 
C(1) 40600(30) 48920(30) 62552(8) 203(4) 
C(2) 20770(30) 45310(30) 62993(9) 228(5) 
C(3) 17000(30) 29830(30) 64929(10) 254(5) 
C(4) 11800(30) 19040(30) 61504(11) 301(5) 
C(5) 8120(30) 4840(30) 63209(13) 365(6) 
C(6) 9650(40) 1220(30) 68287(12) 378(6) 
C(7) 14440(40) 11840(30) 71745(12) 363(6) 
C(8) 17930(30) 26150(30) 70102(10) 305(5) 
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C(9) 11240(30) 56730(30) 66066(10) 263(5) 
C(10) -2930(30) 63250(30) 64348(12) 344(6) 
C(11) 43340(30) 65720(30) 61761(9) 216(4) 
C(12) 35600(30) 71790(30) 56886(9) 270(5) 
C(13) 48620(40) 78740(30) 53139(9) 297(5) 
C(14) 55050(40) 93870(30) 54684(10) 308(5) 
C(15) 65400(30) 94390(30) 59605(10) 292(5) 
C(16) 55380(30) 90340(30) 64394(10) 289(5) 
C(17) 52000(30) 74110(30) 65029(9) 237(5) 
C(18) 49700(30) 43240(20) 67335(8) 184(4) 
C(19) 68200(40) 25170(30) 70738(10) 337(6) 
C(20) 48010(30) 41220(20) 57798(8) 191(4) 
C(21) 73250(30) 37220(30) 53078(9) 288(5) 
________________________________________________________________________ 
  
Table 3.   Bond lengths [≈] and angles [∞] for  p15559. 
_____________________________________________________  
O(1)-C(18)  1.210(3) 
O(2)-C(18)  1.334(3) 
O(2)-C(19)  1.441(3) 
O(3)-C(20)  1.194(3) 
O(4)-C(20)  1.336(3) 
O(4)-C(21)  1.440(3) 
C(1)-C(2)  1.577(3) 
C(1)-C(11)  1.558(3) 
C(1)-C(18)  1.530(3) 
C(1)-C(20)  1.541(3) 
C(2)-H(2)  1.0000 
C(2)-C(3)  1.526(3) 
C(2)-C(9)  1.509(3) 
C(3)-C(4)  1.391(3) 
C(3)-C(8)  1.400(4) 
C(4)-H(4)  0.9500 
C(4)-C(5)  1.397(4) 
C(5)-H(5)  0.9500 
C(5)-C(6)  1.377(5) 
Supporting Information for Liu, Okamoto, Alexy, Hong, Tran, and Stoltz SI 47 
C(6)-H(6)  0.9500 
C(6)-C(7)  1.377(4) 
C(7)-H(7)  0.9500 
C(7)-C(8)  1.398(4) 
C(8)-H(8)  0.9500 
C(9)-H(9)  0.9500 
C(9)-C(10)  1.328(4) 
C(10)-H(10A)  0.9500 
C(10)-H(10B)  0.9500 
C(11)-C(12)  1.517(3) 
C(11)-C(17)  1.330(3) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(12)-C(13)  1.545(4) 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(13)-C(14)  1.520(4) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(14)-C(15)  1.521(4) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(15)-C(16)  1.522(4) 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(16)-C(17)  1.510(3) 
C(17)-H(17)  0.9500 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
C(21)-H(21C)  0.9800 
 
C(18)-O(2)-C(19) 116.30(18) 
C(20)-O(4)-C(21) 115.29(18) 
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C(11)-C(1)-C(2) 110.31(18) 
C(18)-C(1)-C(2) 108.65(18) 
C(18)-C(1)-C(11) 112.22(18) 
C(18)-C(1)-C(20) 109.73(18) 
C(20)-C(1)-C(2) 109.16(18) 
C(20)-C(1)-C(11) 106.72(18) 
C(1)-C(2)-H(2) 106.4 
C(3)-C(2)-C(1) 113.83(19) 
C(3)-C(2)-H(2) 106.4 
C(9)-C(2)-C(1) 111.94(19) 
C(9)-C(2)-H(2) 106.4 
C(9)-C(2)-C(3) 111.37(19) 
C(4)-C(3)-C(2) 119.5(2) 
C(4)-C(3)-C(8) 118.1(2) 
C(8)-C(3)-C(2) 122.3(2) 
C(3)-C(4)-H(4) 119.8 
C(3)-C(4)-C(5) 120.4(3) 
C(5)-C(4)-H(4) 119.8 
C(4)-C(5)-H(5) 119.6 
C(6)-C(5)-C(4) 120.9(3) 
C(6)-C(5)-H(5) 119.6 
C(5)-C(6)-H(6) 120.3 
C(7)-C(6)-C(5) 119.5(3) 
C(7)-C(6)-H(6) 120.3 
C(6)-C(7)-H(7) 119.9 
C(6)-C(7)-C(8) 120.2(3) 
C(8)-C(7)-H(7) 119.9 
C(3)-C(8)-H(8) 119.6 
C(7)-C(8)-C(3) 120.8(3) 
C(7)-C(8)-H(8) 119.6 
C(2)-C(9)-H(9) 118.9 
C(10)-C(9)-C(2) 122.2(2) 
C(10)-C(9)-H(9) 118.9 
C(9)-C(10)-H(10A) 120.0 
C(9)-C(10)-H(10B) 120.0 
H(10A)-C(10)-H(10B) 120.0 
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C(12)-C(11)-C(1) 114.59(19) 
C(17)-C(11)-C(1) 123.1(2) 
C(17)-C(11)-C(12) 122.3(2) 
C(11)-C(12)-H(12A) 108.5 
C(11)-C(12)-H(12B) 108.5 
C(11)-C(12)-C(13) 115.3(2) 
H(12A)-C(12)-H(12B) 107.5 
C(13)-C(12)-H(12A) 108.5 
C(13)-C(12)-H(12B) 108.5 
C(12)-C(13)-H(13A) 108.6 
C(12)-C(13)-H(13B) 108.6 
H(13A)-C(13)-H(13B) 107.6 
C(14)-C(13)-C(12) 114.6(2) 
C(14)-C(13)-H(13A) 108.6 
C(14)-C(13)-H(13B) 108.6 
C(13)-C(14)-H(14A) 108.4 
C(13)-C(14)-H(14B) 108.4 
C(13)-C(14)-C(15) 115.3(2) 
H(14A)-C(14)-H(14B) 107.5 
C(15)-C(14)-H(14A) 108.4 
C(15)-C(14)-H(14B) 108.4 
C(14)-C(15)-H(15A) 108.5 
C(14)-C(15)-H(15B) 108.5 
C(14)-C(15)-C(16) 115.0(2) 
H(15A)-C(15)-H(15B) 107.5 
C(16)-C(15)-H(15A) 108.5 
C(16)-C(15)-H(15B) 108.5 
C(15)-C(16)-H(16A) 108.6 
C(15)-C(16)-H(16B) 108.6 
H(16A)-C(16)-H(16B) 107.6 
C(17)-C(16)-C(15) 114.6(2) 
C(17)-C(16)-H(16A) 108.6 
C(17)-C(16)-H(16B) 108.6 
C(11)-C(17)-C(16) 125.4(2) 
C(11)-C(17)-H(17) 117.3 
C(16)-C(17)-H(17) 117.3 
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O(1)-C(18)-O(2) 123.1(2) 
O(1)-C(18)-C(1) 124.1(2) 
O(2)-C(18)-C(1) 112.58(18) 
O(2)-C(19)-H(19A) 109.5 
O(2)-C(19)-H(19B) 109.5 
O(2)-C(19)-H(19C) 109.5 
H(19A)-C(19)-H(19B) 109.5 
H(19A)-C(19)-H(19C) 109.5 
H(19B)-C(19)-H(19C) 109.5 
O(3)-C(20)-O(4) 123.9(2) 
O(3)-C(20)-C(1) 125.6(2) 
O(4)-C(20)-C(1) 110.38(18) 
O(4)-C(21)-H(21A) 109.5 
O(4)-C(21)-H(21B) 109.5 
O(4)-C(21)-H(21C) 109.5 
H(21A)-C(21)-H(21B) 109.5 
H(21A)-C(21)-H(21C) 109.5 
H(21B)-C(21)-H(21C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (≈2x 104) for p15559.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(1) 333(9)  280(8) 183(7)  -48(7) -16(7)  -5(7) 
O(2) 272(8)  184(7) 234(8)  -17(6) -28(7)  29(7) 
O(3) 275(9)  437(10) 271(9)  -183(8) 0(7)  -67(8) 
O(4) 200(8)  270(8) 189(7)  -67(6) 31(6)  6(7) 
C(1) 184(10)  259(11) 166(9)  -48(8) -11(8)  10(9) 
C(2) 192(10)  258(11) 234(11)  -40(9) -7(8)  -12(9) 
C(3) 190(10)  242(11) 330(12)  -54(10) 10(9)  2(9) 
C(4) 232(11)  291(12) 382(13)  -85(11) 19(10)  2(10) 
C(5) 244(12)  264(12) 587(18)  -120(12) 35(12)  -9(10) 
C(6) 279(13)  229(12) 625(18)  26(12) 73(12)  -13(11) 
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C(7) 288(13)  336(13) 466(16)  53(12) 30(12)  -15(11) 
C(8) 250(12)  326(13) 339(13)  -26(11) 54(10)  -43(10) 
C(9) 224(11)  237(11) 329(12)  -54(10) 16(10)  -12(9) 
C(10) 238(12)  258(12) 536(16)  -36(12) -13(12)  9(10) 
C(11) 175(10)  247(11) 227(10)  -37(9) 15(9)  7(8) 
C(12) 261(12)  250(12) 298(12)  3(10) -70(10)  -14(10) 
C(13) 365(13)  291(12) 237(11)  -11(10) -38(10)  32(11) 
C(14) 373(14)  258(11) 294(12)  53(10) 1(11)  2(10) 
C(15) 274(12)  220(11) 383(14)  14(10) -49(10)  -2(10) 
C(16) 335(13)  211(11) 320(12)  -46(10) -59(11)  -18(10) 
C(17) 229(11)  236(11) 247(11)  -5(9) -12(9)  -2(9) 
C(18) 209(10)  154(9) 189(10)  -23(8) -5(8)  -42(8) 
C(19) 455(15)  255(12) 301(13)  35(11) -67(12)  103(12) 
C(20) 218(10)  189(10) 165(10)  -10(8) -2(8)  -3(9) 
C(21) 313(13)  338(13) 213(11)  -62(10) 103(10)  6(10) 
________________________________________________________________________ 
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for p15559. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(2) 1602 4583 5945 27 
H(4) 1074 2134 5798 36 
H(5) 452 -242 6083 44 
H(6) 741 -853 6940 45 
H(7) 1538 944 7526 44 
H(8) 2097 3345 7253 37 
H(9) 1551 5935 6934 32 
H(10A) -738 6077 6108 41 
H(10B) -862 7040 6638 41 
H(12A) 2691 7930 5780 32 
H(12B) 2950 6373 5511 32 
H(13A) 5865 7209 5281 36 
H(13B) 4312 7949 4974 36 
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H(14A) 4498 10046 5505 37 
H(14B) 6230 9779 5189 37 
H(15A) 7007 10443 6003 35 
H(15B) 7532 8761 5928 35 
H(16A) 6187 9387 6740 35 
H(16B) 4419 9556 6434 35 
H(17) 5641 6951 6801 28 
H(19A) 7662 1791 6955 51 
H(19B) 5985 2039 7300 51 
H(19C) 7417 3299 7260 51 
H(21A) 6846 4065 4983 43 
H(21B) 7153 2659 5338 43 
H(21C) 8561 3943 5320 43 
________________________________________________________________________
Table 6.  Torsion angles [∞] for p15559. 
________________________________________________________________  
C(1)-C(2)-C(3)-C(4) -103.3(3) 
C(1)-C(2)-C(3)-C(8) 79.2(3) 
C(1)-C(2)-C(9)-C(10) 128.7(3) 
C(1)-C(11)-C(12)-C(13) -119.0(2) 
C(1)-C(11)-C(17)-C(16) 178.5(2) 
C(2)-C(1)-C(11)-C(12) -62.6(2) 
C(2)-C(1)-C(11)-C(17) 118.5(2) 
C(2)-C(1)-C(18)-O(1) -67.1(3) 
C(2)-C(1)-C(18)-O(2) 107.8(2) 
C(2)-C(1)-C(20)-O(3) 0.4(3) 
C(2)-C(1)-C(20)-O(4) 177.69(18) 
C(2)-C(3)-C(4)-C(5) -179.4(2) 
C(2)-C(3)-C(8)-C(7) -179.8(2) 
C(3)-C(2)-C(9)-C(10) -102.6(3) 
C(3)-C(4)-C(5)-C(6) -0.3(4) 
C(4)-C(3)-C(8)-C(7) 2.7(4) 
C(4)-C(5)-C(6)-C(7) 1.6(4) 
C(5)-C(6)-C(7)-C(8) -0.8(4) 
C(6)-C(7)-C(8)-C(3) -1.4(4) 
C(8)-C(3)-C(4)-C(5) -1.8(4) 
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C(9)-C(2)-C(3)-C(4) 129.0(2) 
C(9)-C(2)-C(3)-C(8) -48.5(3) 
C(11)-C(1)-C(2)-C(3) -167.21(18) 
C(11)-C(1)-C(2)-C(9) -39.8(3) 
C(11)-C(1)-C(18)-O(1) 55.1(3) 
C(11)-C(1)-C(18)-O(2) -129.96(19) 
C(11)-C(1)-C(20)-O(3) -118.8(3) 
C(11)-C(1)-C(20)-O(4) 58.5(2) 
C(11)-C(12)-C(13)-C(14) -75.8(3) 
C(12)-C(11)-C(17)-C(16) -0.3(4) 
C(12)-C(13)-C(14)-C(15) 64.0(3) 
C(13)-C(14)-C(15)-C(16) -64.8(3) 
C(14)-C(15)-C(16)-C(17) 75.6(3) 
C(15)-C(16)-C(17)-C(11) -59.5(3) 
C(17)-C(11)-C(12)-C(13) 59.9(3) 
C(18)-C(1)-C(2)-C(3) -43.8(2) 
C(18)-C(1)-C(2)-C(9) 83.6(2) 
C(18)-C(1)-C(11)-C(12) 176.12(19) 
C(18)-C(1)-C(11)-C(17) -2.8(3) 
C(18)-C(1)-C(20)-O(3) 119.4(3) 
C(18)-C(1)-C(20)-O(4) -63.3(2) 
C(19)-O(2)-C(18)-O(1) -4.3(3) 
C(19)-O(2)-C(18)-C(1) -179.2(2) 
C(20)-C(1)-C(2)-C(3) 75.8(2) 
C(20)-C(1)-C(2)-C(9) -156.8(2) 
C(20)-C(1)-C(11)-C(12) 55.9(2) 
C(20)-C(1)-C(11)-C(17) -123.0(2) 
C(20)-C(1)-C(18)-O(1) 173.6(2) 
C(20)-C(1)-C(18)-O(2) -11.5(3) 
C(21)-O(4)-C(20)-O(3) -6.4(3) 
C(21)-O(4)-C(20)-C(1) 176.25(19) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Crystal Structure Analysis of Diol S5aa (smaple No.: p15573): 
 
 The diol S5aa (>99% ee) was recrystallized from Et2O/hexanes (liquid/liquid 
diffusion) at 0 ºC to provide suitable crystals for X-ray analysis, m.p. = 91 – 92 ºC 
(hexanes/Et2O). 
 
Table 1.  Crystal data and structure refinement for p15573. 
Identification code  p15573 
Empirical formula  C19 H26 O2 
Formula weight  286.40 
Temperature  100 K 
Wavelength  1.54178 ≈ 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 6.1787(8) ≈ α= 90∞ 
 b = 9.0018(11) ≈ β= 90∞ 
 c = 29.470(3) ≈ γ = 90∞ 
Volume 1639.1(3) ≈3 
Z 4 
Density (calculated) 1.161 Mg/m3 
Absorption coefficient 0.569 mm-1 
F(000) 624 
Crystal size 0.17 x 0.15 x 0.10 mm3 
Theta range for data collection 2.999 to 79.168∞. 
Index ranges -7<=h<=6, -11<=k<=11, -37<=l<=37 
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Reflections collected 42476 
Independent reflections 3528 [R(int) = 0.0365] 
Completeness to theta = 67.000∞ 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.0000 and 0.9358 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3528 / 0 / 274 
Goodness-of-fit on F2 1.065 
Final R indices [I>2sigma(I)] R1 = 0.0269, wR2 = 0.0674 
R indices (all data) R1 = 0.0276, wR2 = 0.0680 
Absolute structure parameter 0.06(3) 
Extinction coefficient n/a 
Largest diff. peak and hole 0.151 and -0.151 e.≈-3 
 
Table 2.  Atomic coordinates  ( x 105) and equivalent  isotropic displacement parameters 
(≈2x 104) for p15573.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
O(1) 98299(14) 29698(10) 46715(3) 231(2) 
O(2) 39847(15) 37085(11) 45850(3) 264(2) 
C(1) 77350(20) 60425(14) 40871(4) 185(2) 
C(2) 62050(20) 65375(14) 37135(4) 240(3) 
C(3) 58950(30) 82309(16) 36918(4) 332(4) 
C(4) 55850(20) 89964(16) 41547(5) 297(3) 
C(5) 77130(20) 94951(15) 43706(4) 263(3) 
C(6) 91700(20) 82470(15) 45366(5) 257(3) 
C(7) 96570(20) 70494(14) 41772(5) 241(3) 
C(8) 73960(20) 47967(13) 43291(4) 179(2) 
C(9) 87550(20) 43732(14) 47335(4) 211(3) 
C(10) 56100(20) 36983(14) 42365(4) 218(3) 
C(11) 70390(70) 59480(50) 32407(13) 248(7) 
C(12) 54900(30) 62780(20) 28662(5) 255(5) 
C(13) 39140(40) 53410(20) 27498(8) 242(5) 
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C(14) 23070(60) 55120(40) 23888(11) 233(5) 
C(15) 5980(50) 45320(40) 23756(10) 316(6) 
C(16) -10090(70) 46330(50) 20517(16) 387(9) 
C(17) -9830(90) 57330(60) 17220(20) 343(11) 
C(18) 8040(100) 67220(60) 17270(13) 372(9) 
C(19) 24250(60) 66010(40) 20567(14) 323(7) 
C(11A) 64700(300) 57900(200) 32940(70) 420(50) 
C(12A) 44830(140) 55960(90) 29580(30) 261(19) 
C(13A) 43160(110) 60900(80) 25420(20) 240(20) 
C(14A) 23680(160) 59780(130) 22540(40) 143(19) 
C(15A) 5200(300) 51020(120) 23290(40) 340(30) 
C(16A) -12300(300) 52140(130) 20330(60) 290(30) 
C(17A) -9100(500) 61600(200) 16800(90) 470(60) 
C(18A) 6600(400) 69300(200) 15880(50) 340(40) 
C(19A) 23080(170) 68610(120) 18680(40) 210(20) 
________________________________________________________________________ 
  
Table 3.   Bond lengths [≈] and angles [∞] for  p15573. 
_____________________________________________________  
O(1)-H(1)  0.8400 
O(1)-C(9)  1.4389(16) 
O(2)-H(2)  0.8400 
O(2)-C(10)  1.4365(16) 
C(1)-C(2)  1.5181(17) 
C(1)-C(7)  1.5171(18) 
C(1)-C(8)  1.3455(17) 
C(2)-H(2A)  1.0000 
C(2)-H(2B)  1.0000 
C(2)-C(3)  1.5376(19) 
C(2)-C(11)  1.577(4) 
C(2)-C(11A)  1.42(2) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(3)-C(4)  1.5403(18) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
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C(4)-C(5)  1.528(2) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(5)-C(6)  1.5205(19) 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(6)-C(7)  1.5410(19) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(9)  1.5067(16) 
C(8)-C(10)  1.5066(17) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(11)-C(12)  1.491(5) 
C(12)-H(12)  0.9500 
C(12)-C(13)  1.333(3) 
C(13)-H(13)  0.9500 
C(13)-C(14)  1.463(4) 
C(14)-C(15)  1.376(5) 
C(14)-C(19)  1.387(4) 
C(15)-H(15)  0.9500 
C(15)-C(16)  1.380(6) 
C(16)-H(16)  0.9500 
C(16)-C(17)  1.389(6) 
C(17)-H(17)  0.9500 
C(17)-C(18)  1.418(9) 
C(18)-H(18)  0.9500 
C(18)-C(19)  1.400(5) 
C(19)-H(19)  0.9500 
C(11A)-H(11C)  0.9900 
C(11A)-H(11D)  0.9900 
C(11A)-C(12A)  1.59(2) 
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C(12A)-H(12A)  0.9500 
C(12A)-C(13A)  1.307(12) 
C(13A)-H(13A)  0.9500 
C(13A)-C(14A)  1.477(12) 
C(14A)-C(15A)  1.405(19) 
C(14A)-C(19A)  1.387(13) 
C(15A)-H(15A)  0.9500 
C(15A)-C(16A)  1.39(2) 
C(16A)-H(16A)  0.9500 
C(16A)-C(17A)  1.36(3) 
C(17A)-H(17A)  0.9500 
C(17A)-C(18A)  1.22(4) 
C(18A)-H(18A)  0.9500 
C(18A)-C(19A)  1.31(2) 
C(19A)-H(19A)  0.9500 
 
C(9)-O(1)-H(1) 109.5 
C(10)-O(2)-H(2) 109.5 
C(7)-C(1)-C(2) 116.03(11) 
C(8)-C(1)-C(2) 122.15(12) 
C(8)-C(1)-C(7) 121.82(11) 
C(1)-C(2)-H(2A) 107.9 
C(1)-C(2)-H(2B) 103.1 
C(1)-C(2)-C(3) 113.50(11) 
C(1)-C(2)-C(11) 109.8(2) 
C(3)-C(2)-H(2A) 107.9 
C(3)-C(2)-H(2B) 103.1 
C(3)-C(2)-C(11) 109.72(19) 
C(11)-C(2)-H(2A) 107.9 
C(11A)-C(2)-C(1) 114.9(8) 
C(11A)-C(2)-H(2B) 103.1 
C(11A)-C(2)-C(3) 116.7(9) 
C(2)-C(3)-H(3A) 108.5 
C(2)-C(3)-H(3B) 108.5 
C(2)-C(3)-C(4) 114.97(11) 
H(3A)-C(3)-H(3B) 107.5 
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C(4)-C(3)-H(3A) 108.5 
C(4)-C(3)-H(3B) 108.5 
C(3)-C(4)-H(4A) 108.9 
C(3)-C(4)-H(4B) 108.9 
H(4A)-C(4)-H(4B) 107.8 
C(5)-C(4)-C(3) 113.15(13) 
C(5)-C(4)-H(4A) 108.9 
C(5)-C(4)-H(4B) 108.9 
C(4)-C(5)-H(5A) 108.5 
C(4)-C(5)-H(5B) 108.5 
H(5A)-C(5)-H(5B) 107.5 
C(6)-C(5)-C(4) 115.23(11) 
C(6)-C(5)-H(5A) 108.5 
C(6)-C(5)-H(5B) 108.5 
C(5)-C(6)-H(6A) 108.7 
C(5)-C(6)-H(6B) 108.7 
C(5)-C(6)-C(7) 114.29(11) 
H(6A)-C(6)-H(6B) 107.6 
C(7)-C(6)-H(6A) 108.7 
C(7)-C(6)-H(6B) 108.7 
C(1)-C(7)-C(6) 112.66(10) 
C(1)-C(7)-H(7A) 109.1 
C(1)-C(7)-H(7B) 109.1 
C(6)-C(7)-H(7A) 109.1 
C(6)-C(7)-H(7B) 109.1 
H(7A)-C(7)-H(7B) 107.8 
C(1)-C(8)-C(9) 122.91(11) 
C(1)-C(8)-C(10) 124.41(11) 
C(10)-C(8)-C(9) 112.66(10) 
O(1)-C(9)-C(8) 112.27(10) 
O(1)-C(9)-H(9A) 109.1 
O(1)-C(9)-H(9B) 109.1 
C(8)-C(9)-H(9A) 109.1 
C(8)-C(9)-H(9B) 109.1 
H(9A)-C(9)-H(9B) 107.9 
O(2)-C(10)-C(8) 112.23(10) 
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O(2)-C(10)-H(10A) 109.2 
O(2)-C(10)-H(10B) 109.2 
C(8)-C(10)-H(10A) 109.2 
C(8)-C(10)-H(10B) 109.2 
H(10A)-C(10)-H(10B) 107.9 
C(2)-C(11)-H(11A) 109.2 
C(2)-C(11)-H(11B) 109.2 
H(11A)-C(11)-H(11B) 107.9 
C(12)-C(11)-C(2) 112.2(3) 
C(12)-C(11)-H(11A) 109.2 
C(12)-C(11)-H(11B) 109.2 
C(11)-C(12)-H(12) 118.9 
C(13)-C(12)-C(11) 122.2(2) 
C(13)-C(12)-H(12) 118.9 
C(12)-C(13)-H(13) 116.0 
C(12)-C(13)-C(14) 128.0(2) 
C(14)-C(13)-H(13) 116.0 
C(15)-C(14)-C(13) 118.3(3) 
C(15)-C(14)-C(19) 118.3(3) 
C(19)-C(14)-C(13) 123.5(3) 
C(14)-C(15)-H(15) 119.0 
C(14)-C(15)-C(16) 121.9(3) 
C(16)-C(15)-H(15) 119.0 
C(15)-C(16)-H(16) 119.2 
C(15)-C(16)-C(17) 121.5(4) 
C(17)-C(16)-H(16) 119.2 
C(16)-C(17)-H(17) 121.6 
C(16)-C(17)-C(18) 116.7(4) 
C(18)-C(17)-H(17) 121.6 
C(17)-C(18)-H(18) 119.5 
C(19)-C(18)-C(17) 121.0(4) 
C(19)-C(18)-H(18) 119.5 
C(14)-C(19)-C(18) 120.5(3) 
C(14)-C(19)-H(19) 119.8 
C(18)-C(19)-H(19) 119.8 
C(2)-C(11A)-H(11C) 107.2 
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C(2)-C(11A)-H(11D) 107.2 
C(2)-C(11A)-C(12A) 120.5(11) 
H(11C)-C(11A)-H(11D) 106.8 
C(12A)-C(11A)-H(11C) 107.2 
C(12A)-C(11A)-H(11D) 107.2 
C(11A)-C(12A)-H(12A) 116.2 
C(13A)-C(12A)-C(11A) 127.6(9) 
C(13A)-C(12A)-H(12A) 116.2 
C(12A)-C(13A)-H(13A) 117.3 
C(12A)-C(13A)-C(14A) 125.5(9) 
C(14A)-C(13A)-H(13A) 117.3 
C(15A)-C(14A)-C(13A) 127.6(11) 
C(19A)-C(14A)-C(13A) 117.0(9) 
C(19A)-C(14A)-C(15A) 115.4(9) 
C(14A)-C(15A)-H(15A) 120.3 
C(16A)-C(15A)-C(14A) 119.4(10) 
C(16A)-C(15A)-H(15A) 120.3 
C(15A)-C(16A)-H(16A) 122.8 
C(17A)-C(16A)-C(15A) 114.4(18) 
C(17A)-C(16A)-H(16A) 122.8 
C(16A)-C(17A)-H(17A) 115.1 
C(18A)-C(17A)-C(16A) 130(3) 
C(18A)-C(17A)-H(17A) 115.1 
C(17A)-C(18A)-H(18A) 121.7 
C(17A)-C(18A)-C(19A) 116.5(17) 
C(19A)-C(18A)-H(18A) 121.7 
C(14A)-C(19A)-H(19A) 117.8 
C(18A)-C(19A)-C(14A) 124.4(11) 
C(18A)-C(19A)-H(19A) 117.8 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (≈2x 104) for p15573.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
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________________________________________________________________________  
O(1) 172(4)  230(4) 292(4)  75(4) -21(4)  6(3) 
O(2) 173(4)  331(5) 289(5)  115(4) 15(4)  -10(4) 
C(1) 175(5)  219(6) 162(5)  19(4) 8(4)  23(5) 
C(2) 308(7)  249(6) 164(5)  9(5) -43(5)  76(5) 
C(3) 542(10)  269(7) 186(6)  19(5) -72(6)  135(7) 
C(4) 369(8)  290(7) 232(6)  -21(5) -40(6)  122(6) 
C(5) 343(7)  220(6) 227(6)  15(5) 68(6)  -12(6) 
C(6) 238(6)  254(6) 279(6)  15(5) -9(5)  -67(5) 
C(7) 189(6)  230(6) 305(6)  53(5) 47(5)  -20(5) 
C(8) 166(6)  211(6) 161(5)  10(4) -4(5)  3(5) 
C(9) 220(6)  216(6) 198(6)  37(4) -40(5)  -3(5) 
C(10) 190(6)  225(6) 238(6)  3(5) -7(5)  -27(5) 
C(11) 340(20)  275(11) 130(13)  -19(10) 32(13)  83(12) 
C(12) 381(11)  220(9) 163(8)  -7(6) -23(7)  -7(9) 
C(13) 335(11)  196(10) 196(10)  -24(8) 23(9)  16(8) 
C(14) 301(12)  217(14) 179(13)  -48(10) 27(11)  12(12) 
C(15) 287(11)  446(19) 215(11)  25(13) 44(8)  -46(15) 
C(16) 284(14)  590(20) 284(12)  10(20) 20(10)  -146(19) 
C(17) 314(15)  490(30) 228(16)  -88(19) -10(10)  -106(17) 
C(18) 550(20)  312(17) 250(20)  -34(15) -60(20)  -42(15) 
C(19) 457(14)  261(16) 252(18)  -39(14) -111(17)  -76(13) 
C(11A) 310(80)  680(90) 270(50)  240(50) 220(50)  280(60) 
C(12A) 310(40)  210(40) 260(40)  -60(30) 60(30)  -70(30) 
C(13A) 220(30)  260(40) 230(40)  -60(30) 20(30)  -20(30) 
C(14A) 230(30)  110(50) 100(50)  20(30) -30(40)  -50(40) 
C(15A) 670(80)  170(50) 170(40)  70(40) 100(40)  80(50) 
C(16A) 260(50)  320(60) 300(60)  -130(60) 80(40)  -110(50) 
C(17A) 770(110)  430(110) 220(70)  -200(80) 120(60)  -150(80) 
C(18A) 560(90)  260(60) 190(60)  -60(50) 220(70)  -10(50) 
C(19A) 230(50)  160(40) 250(50)  -110(40) 30(50)  -70(30) 
________________________________________________________________________ 
  
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for p15573. 
________________________________________________________________________ 
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 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1) 11102 3117 4581 35 
H(2) 4453 3262 4815 40 
H(2A) 4760 6077 3773 29 
H(2B) 4766 6175 3822 29 
H(3A) 4617 8447 3500 40 
H(3B) 7174 8673 3541 40 
H(4A) 4637 9873 4115 36 
H(4B) 4844 8300 4363 36 
H(5A) 8525 10093 4146 32 
H(5B) 7375 10152 4631 32 
H(6A) 8476 7766 4801 31 
H(6B) 10556 8681 4641 31 
H(7A) 10085 7541 3890 29 
H(7B) 10894 6439 4281 29 
H(9A) 9852 5155 4787 25 
H(9B) 7819 4318 5006 25 
H(10A) 4927 3938 3942 26 
H(10B) 6237 2689 4214 26 
H(11A) 8452 6413 3171 30 
H(11B) 7262 4860 3260 30 
H(12) 5630 7187 2705 31 
H(13) 3823 4452 2923 29 
H(15) 522 3763 2596 38 
H(16) -2160 3933 2055 46 
H(17) -2106 5820 1503 41 
H(18) 901 7479 1503 45 
H(19) 3615 7269 2053 39 
H(11C) 7024 4783 3363 50 
H(11D) 7625 6313 3125 50 
H(12A) 3276 5059 3071 31 
H(13A) 5551 6561 2415 29 
H(15A) 465 4438 2579 41 
H(16A) -2533 4673 2075 35 
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H(17A) -2083 6235 1473 56 
H(18A) 686 7555 1327 41 
H(19A) 3543 7451 1802 26 
________________________________________________________________________ 
 
Table 6.  Torsion angles [∞] for p15573. 
________________________________________________________________  
C(1)-C(2)-C(3)-C(4) -43.6(2) 
C(1)-C(2)-C(11)-C(12) 174.6(2) 
C(1)-C(2)-C(11A)-C(12A) 151.8(11) 
C(1)-C(8)-C(9)-O(1) -119.85(13) 
C(1)-C(8)-C(10)-O(2) -110.60(13) 
C(2)-C(1)-C(7)-C(6) 90.17(13) 
C(2)-C(1)-C(8)-C(9) -173.18(11) 
C(2)-C(1)-C(8)-C(10) 5.28(19) 
C(2)-C(3)-C(4)-C(5) 90.06(17) 
C(2)-C(11)-C(12)-C(13) -90.1(3) 
C(2)-C(11A)-C(12A)-C(13A) 119.6(12) 
C(3)-C(2)-C(11)-C(12) -60.0(3) 
C(3)-C(2)-C(11A)-C(12A) -71.7(15) 
C(3)-C(4)-C(5)-C(6) -69.81(15) 
C(4)-C(5)-C(6)-C(7) 52.74(15) 
C(5)-C(6)-C(7)-C(1) -73.65(14) 
C(7)-C(1)-C(2)-C(3) -36.48(17) 
C(7)-C(1)-C(2)-C(11) 86.7(2) 
C(7)-C(1)-C(2)-C(11A) 101.4(8) 
C(7)-C(1)-C(8)-C(9) 5.86(18) 
C(7)-C(1)-C(8)-C(10) -175.69(11) 
C(8)-C(1)-C(2)-C(3) 142.60(14) 
C(8)-C(1)-C(2)-C(11) -94.2(2) 
C(8)-C(1)-C(2)-C(11A) -79.5(8) 
C(8)-C(1)-C(7)-C(6) -88.92(15) 
C(9)-C(8)-C(10)-O(2) 67.99(13) 
C(10)-C(8)-C(9)-O(1) 61.53(13) 
C(11)-C(2)-C(3)-C(4) -166.9(2) 
C(11)-C(12)-C(13)-C(14) -179.2(2) 
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C(12)-C(13)-C(14)-C(15) -169.1(2) 
C(12)-C(13)-C(14)-C(19) 11.5(4) 
C(13)-C(14)-C(15)-C(16) 178.8(3) 
C(13)-C(14)-C(19)-C(18) -178.5(3) 
C(14)-C(15)-C(16)-C(17) 0.0(6) 
C(15)-C(14)-C(19)-C(18) 2.1(5) 
C(15)-C(16)-C(17)-C(18) 1.6(7) 
C(16)-C(17)-C(18)-C(19) -1.3(8) 
C(17)-C(18)-C(19)-C(14) -0.5(7) 
C(19)-C(14)-C(15)-C(16) -1.8(5) 
C(11A)-C(2)-C(3)-C(4) 179.2(8) 
C(11A)-C(12A)-C(13A)-C(14A) -175.2(11) 
C(12A)-C(13A)-C(14A)-C(15A) -13.2(14) 
C(12A)-C(13A)-C(14A)-C(19A) 165.1(8) 
C(13A)-C(14A)-C(15A)-C(16A) 175.8(10) 
C(13A)-C(14A)-C(19A)-C(18A) -177.1(11) 
C(14A)-C(15A)-C(16A)-C(17A) 2.3(19) 
C(15A)-C(14A)-C(19A)-C(18A) 1.4(15) 
C(15A)-C(16A)-C(17A)-C(18A) -1(3) 
C(16A)-C(17A)-C(18A)-C(19A) 0(3) 
C(17A)-C(18A)-C(19A)-C(14A) 0(2) 
C(19A)-C(14A)-C(15A)-C(16A) -2.5(15) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 Table 7.  Hydrogen bonds for p15573  [≈ and ∞]. 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 O(1)-H(1)...O(2)#1 0.84 1.86 2.6640(13) 160.0 
 O(2)-H(2)...O(1)#2 0.84 1.89 2.7121(13) 165.9 
________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x+1,y,z    #2 x-1/2,-y+1/2,-z+1       
1H NMR and 13C NMR Spectra                    
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